FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Lagos, T
   Armstrong, M
   Homem-de-Mello, T
   Lagos, G
   Saure, D
AF Lagos, Tomas
   Armstrong, Margaret
   Homem-de-Mello, Tito
   Lagos, Guido
   Saure, Denis
TI A framework for adaptive open-pit mining planning under geological
   uncertainty
SO OPTIMIZATION AND ENGINEERING
LA English
DT Article; Early Access
DE Mine planning; Geostatistics; Stochastic optimization; Adaptive
   algorithms; Iterative learning algorithm
ID STOCHASTIC PROGRAMS; FLEXIBILITY; SIMULATION
AB Mine planning optimization aims at maximizing the profit obtained from extracting valuable ore. Beyond its theoretical complexity-the open-pit mining problem with capacity constraints reduces to a knapsack problem with precedence constraints, which is NP-hard-practical instances of the problem usually involve a large to very large number of decision variables, typically of the order of millions for large mines. Additionally, any comprehensive approach to mine planning ought to consider the underlying geostatistical uncertainty as only limited information obtained from drill hole samples of the mineral is initially available. In this regard, as blocks are extracted sequentially, information about the ore grades of blocks yet to be extracted changes based on the blocks that have already been mined. Thus, the problem lies in the class of multi-period large scale stochastic optimization problems with decision-dependent information uncertainty. Such problems are exceedingly hard to solve, so approximations are required. This paper presents an adaptive optimization scheme for multi-period production scheduling in open-pit mining under geological uncertainty that allows us to solve practical instances of the problem. Our approach is based on a rolling-horizon adaptive optimization framework that learns from new information that becomes available as blocks are mined. By considering the evolution of geostatistical uncertainty, the proposed optimization framework produces an operational policy that reduces the risk of the production schedule. Our numerical tests with mines of moderate sizes show that our rolling horizon adaptive policy gives consistently better results than a non-adaptive stochastic optimization formulation, for a range of realistic problem instances.
C1 [Lagos, Tomas; Saure, Denis] Univ Chile, Dept Ind Engn, Santiago, Chile.
   [Armstrong, Margaret; Homem-de-Mello, Tito] Univ Adolfo Ibanez, Sch Business, Santiago, Chile.
   [Armstrong, Margaret] Univ Chile, Ctr Math Modelling, Santiago, Chile.
   [Lagos, Guido] Univ Adolfo Ibanez, Fac Engn & Sci, Santiago, Chile.
RP Homem-de-Mello, T (corresponding author), Univ Adolfo Ibanez, Sch Business, Santiago, Chile.
EM tito.hmello@uai.cl
FU Programa de Investigacion Asociativa (PIA), Chile [ACT1407]; FONDECYT,
   ChileComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [3180767, 1171145]; FONDECYTComision Nacional
   de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT
   [1181513]
FX This research has been supported by grant Programa de Investigacion
   Asociativa (PIA) ACT1407, Chile. Guido Lagos also acknowledges the
   financial support of FONDECYT Grant 3180767, Chile. Tito Homem-de-Mello
   and Tomas Lagos acknowledge the support of FONDECYT Grant 1171145,
   Chile. Denis Saure acknowledges the support of FONDECYT Grant 1181513.
CR Alonso-Ayuso A, 2014, EUR J OPER RES, V233, P711, DOI 10.1016/j.ejor.2013.08.048
   ARMSTRONG M, 1981, J INT ASS MATH GEOL, V13, P455, DOI 10.1007/BF01079648
   Bassamboo A, 2012, OPER RES, V60, P1423, DOI 10.1287/opre.1120.1107
   BenTal A, 2009, PRINC SER APPL MATH, P1
   Boland N, 2008, OPTIMIZATION ONLINE
   Caers J., 2000, P 6 INT GEOST C CAP, V1, P39
   CHILES J.-P., 2009, GEOSTATISTICS MODELI
   Chod J, 2010, MANAGE SCI, V56, P1030, DOI 10.1287/mnsc.1090.1137
   de Carvalho JP, 2019, MATH GEOSCI, V51, P793, DOI 10.1007/s11004-019-09784-x
   De Lara M, 2017, ADAPTIVE STRATEGIES
   Dimitrakopoulos R., 2004, SME T, V316, P106
   Dowd PA, 2018, ADV APPL STRATEGIC M
   Emery X, 2006, COMPUT GEOSCI-UK, V32, P1615, DOI 10.1016/j.cageo.2006.03.001
   Escudero LF, 2020, EUR J OPER RES, V285, P988, DOI 10.1016/j.ejor.2020.02.046
   Escudero LF, 2017, COMPUT OPER RES, V85, P154, DOI 10.1016/j.cor.2017.04.007
   Del Castillo MF, 2019, RESOUR POLICY, V60, P83, DOI 10.1016/j.resourpol.2018.11.019
   Frazier PI, 2018, RECENT ADV OPTIMIZAT, P255, DOI DOI 10.1287/EDUC.2018.0188
   Gershon M, 1987, INT J MINING GEOLOGI, V5, P1, DOI DOI 10.1007/BF01553529
   Goel V, 2007, MATH PROGRAM, V108, P355, DOI 10.1007/s10107-006-0715-7
   GOMEZHERNANDEZ JJ, 1993, QUANT GEO G, V5, P85
   Goria S, 2004, THESIS
   Hellemo L, 2018, COMPUT MANAG SCI, V15, P369, DOI 10.1007/s10287-018-0330-0
   Homem-de-Mello T., 2014, SURVEYS OPERATIONS R, V19, P56, DOI DOI 10.1016/J.SORMS.2014.05.001
   Kleywegt AJ, 2001, SIAM J OPTIMIZ, V12, P479, DOI 10.1137/S1052623499363220
   KLINGMAN D, 1988, J OPER RES SOC, V39, P805, DOI 10.1057/palgrave.jors.0390902
   Krige D.G., 1951, J CHEM METALL MIN SO, V52, P119, DOI DOI 10.2307/3006914
   Lagos G., 2011, ELECT NOTES DISCRETE, V37, P15, DOI [10.1016/j.endm.2011.05.004, DOI 10.1016/J.ENDM.2011.05.004]
   Lantuejoul C, 2013, GEOSTATISTICAL SIMUL
   Leite A, 2007, T I MIN METALL A, V116, P109, DOI 10.1179/174328607X228848
   Lerchs H., 1965, T CIM, VLXVIII, P17
   Lund PD, 2015, RENEW SUST ENERG REV, V45, P785, DOI 10.1016/j.rser.2015.01.057
   Matheron G., 1973, Advances in Applied Probability, V5, P439, DOI 10.2307/1425829
   Menabde M, 2018, ADV APPL STRATEGIC M
   Moreno E, 2017, P APCOM
   Munoz G, 2018, COMPUT OPTIM APPL, V69, P501, DOI 10.1007/s10589-017-9946-1
   Mustapha H, 2010, MATH GEOSCI, V42, P457, DOI 10.1007/s11004-010-9291-8
   Newman AM, 2010, INTERFACES, V40, P222, DOI 10.1287/inte.1090.0492
   Nicholas G, 2006, P INT MIN MAN C, P69
   Oliver DS, 2008, INVERSE THEORY FOR PETROLEUM RESERVOIR CHARACTERIZATION AND HISTORY MATCHING, P1, DOI 10.1017/CBO9780511535642
   Oliver DS, 2011, COMPUTAT GEOSCI, V15, P185, DOI 10.1007/s10596-010-9194-2
   Powell WB, 2012, OPTIMAL LEARNING
   Ramazan S, 2013, OPTIM ENG, V14, P361, DOI 10.1007/s11081-012-9186-2
   Ravenscroft P, 1992, T I MINING METALLU A, V101
   Rimele A, 2020, RESOUR POLICY, V65, DOI 10.1016/j.resourpol.2019.101570
   Rivera O, 2019, OPER RES
   Shapiro A, 2006, OPER RES LETT, V34, P1, DOI 10.1016/j.orl.2005.02.003
   Shapiro A., 2009, LECT STOCHASTIC PROG
   Smith C, 1978, OPERATIONS RES SOC S
   Soares A, 2001, MATH GEOL, V33, P911, DOI 10.1023/A:1012246006212
   Stewart J, 1976, ROCKY MOUNTAIN MATH, V6, P409, DOI [DOI 10.1216/RMJ-1976-6-3-409, 10.1216/RMJ-1976-6-3-409]
   Zou JK, 2019, MATH PROGRAM, V175, P461, DOI 10.1007/s10107-018-1249-5
NR 51
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-4420
EI 1573-2924
J9 OPTIM ENG
JI Optim. Eng.
DI 10.1007/s11081-020-09557-0
EA SEP 2020
PG 36
WC Engineering, Multidisciplinary; Operations Research & Management
   Science; Mathematics, Interdisciplinary Applications
SC Engineering; Operations Research & Management Science; Mathematics
GA NN7XS
UT WOS:000569001700001
DA 2020-12-01
ER

PT J
AU Armstrong, M
   Langrene, N
   Petter, R
   Chen, W
   Petter, C
AF Armstrong, Margaret
   Langrene, Nicolas
   Petter, Renato
   Chen, Wen
   Petter, Carlos
TI Accounting for tailings dam failures in the valuation of mining projects
SO RESOURCES POLICY
LA English
DT Article
DE Dry processing; Preventive maintenance; Real options; Quantization
ID REAL OPTIONS; COMMODITY PRICES; MINE TAILINGS; IMPACTS
AB The number of major tailings dam failures has doubled over the past 20 years, culminating in the tragic accident at Brumadinho in Brazil where about 300 people lost their lives. In this context, there is a growing demand from mining companies, institutional investors and policymakers alike for updated mining project assessment tools taking account of such risks. As part of this research, this paper develops a real option framework for evaluating mining projects involving tailings dams and their associated risk. Two options are considered beyond standard business-as-usual safety measures: reinforced dam maintenance, and retrofitting a treatment process that reduces the volume of unconsolidated tailings. A closed-form expression was obtained for the expected value of the business-as-usual case; semi-analytic formulas were obtained for the two options for evaluation by dynamic programming with quantization of the price factor. When applied to an iron ore deposit with characteristics similar to the Samarco deposit, the method shows that both options are financially superior to business-as-usual for the mining company, with the dry processing retrofitting option being the most attractive. The sensitivity of the expected values was evaluated over a range of values of the key parameters. This research provides senior decision-makers with tools to evaluate different options regarding tailings dam safety from a financial point of view, and provides financial evidence in favour of safer treatment processes for mining waste.
C1 [Armstrong, Margaret] Univ Adolfo Ibanez, Escuela Negocios, Santiago, Chile.
   [Armstrong, Margaret] Univ Chile, Ctr Math Modelling, Santiago, Chile.
   [Langrene, Nicolas; Chen, Wen] RiskLab, Data61, Commonwealth Sci & Ind Res Org, Melbourne, Vic, Australia.
   [Petter, Renato; Petter, Carlos] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RP Langrene, N (corresponding author), RiskLab, Data61, Commonwealth Sci & Ind Res Org, Melbourne, Vic, Australia.
EM nicolas.langrene@csiro.au
RI Chen, Wen/AAX-5306-2020; Langrene, Nicolas/AAA-9790-2019; Petter,
   Carlos/AAE-9945-2019
OI Chen, Wen/0000-0002-7268-0979; Langrene, Nicolas/0000-0001-7601-4618; 
CR Aba Oud M. A., 2015, APPL MATH FINANCE, V22, P189
   Abdel Sabour S. A., 2006, Engineering Economist, V51, P141, DOI 10.1080/00137910600705210
   Ajak A., 2018, INT J MIN RECLAM ENV
   Amnesty International Canada, 2018, IND RIGHTS CONT BE D
   Amram M, 1998, REAL OPTIONS MANAGIN
   Andersson H., 2007, APPL FINANCIAL EC, V17, P769
   [Anonymous], 2002, EC EFF MIN SPILLS TI
   [Anonymous], 2019, ECONOMIST
   [Anonymous], 2019, REUTERS
   [Anonymous], 2018, SL1D EL BAT COMPL
   [Anonymous], 2018, WISE URANIUM
   Azam S., 2010, GEOTECH N, V24, P50
   Bachouch A., 2019, DEEP NEURAL NE UNPUB
   BALATA A, 2019, ESAIM, V65, P114, DOI DOI 10.1051/proc/201965114
   Bernard JT, 2008, J FORECASTING, V27, P279, DOI 10.1002/for.1061
   Bowker L, 2015, TECHNICAL REPORT
   BRENNAN MJ, 1985, J BUS, V58, P135, DOI 10.1086/296288
   Carneiro A., 2018, P 21 INT SEM PAST TH, P439
   Chen W, 2015, 21ST INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2015), P1063
   Chen W., 2016, P 20 ANN INT REAL OP
   Chen W., 2017, P 22 INT C MOD SIM M
   Cortazar G, 2001, R&D MANAGE, V31, P181, DOI 10.1111/1467-9310.00208
   CORTAZAR G, 1993, J BUS, V66, P517, DOI 10.1086/296616
   Cortazar G., 1998, Q REV EC FINANCE, V38, P755, DOI DOI 10.1016/S1062-9769(99)80100-8
   COUTO RA, 1989, J COMMUNITY PSYCHOL, V17, P236, DOI 10.1002/1520-6629(198907)17:3<236::AID-JCOP2290170306>3.0.CO;2-Z
   Davies M., 2002, GEOTECH NEWS, V20, P31
   de la Vergne J., 2003, HARD ROCK MINERS HDB
   Deng SJ, 2006, ENERGY, V31, P940, DOI 10.1016/j.energy.2005.02.015
   Devon Smith L, 2016, MEASURING MINE LIFE
   Dias M, 2006, 10 ANN INT C REAL OP
   do Carmo FF, 2017, PERSPECT ECOL CONSER, V15, P145, DOI 10.1016/j.pecon.2017.06.002
   Edraki M, 2014, J CLEAN PROD, V84, P411, DOI 10.1016/j.jclepro.2014.04.079
   Fernandes GW, 2016, NAT CONSERVACAO, V14, P35, DOI 10.1016/j.ncon.2016.10.003
   Franks DM, 2011, RESOUR POLICY, V36, P114, DOI 10.1016/j.resourpol.2010.12.001
   Grenadier SR, 1997, J FINANC ECON, V44, P397, DOI 10.1016/S0304-405X(97)00009-3
   Hatje V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11143-x
   Hull J. C., 2014, OPTIONS FUTURES OTHE
   Hume N, 2016, VALE OPENS WORLDS LA
   Kloeden P., 1992, STOCHASTIC MODELLING
   Kossoff D, 2014, APPL GEOCHEM, V51, P229, DOI 10.1016/j.apgeochem.2014.09.010
   Koussis N, 2007, ANN OPER RES, V151, P29, DOI 10.1007/s10479-006-0127-3
   Labonne B, 2016, EXTRACT IND SOC, V3, P651, DOI 10.1016/j.exis.2016.03.010
   Langrene N, 2015, 21ST INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2015), P1077
   Langrene N, 2016, INT J THEOR APPL FIN, V19, DOI 10.1142/S021902491650031X
   Longstaff FA, 2001, REV FINANC STUD, V14, P113, DOI 10.1093/rfs/14.1.113
   Mann NR, 1974, METHODS STAT ANAL RE
   Martin TE, 1999, TAILINGS AND MINE WASTE '99, P287
   Martine K., 2018, VALE BHP SIGN AGREEM
   Milanez B, 2017, VIBRANT VIRT BRAZIL, V14
   Moel A., 1999, BIDDING ANTAMINA MIN
   MYERS SC, 1977, J FINANC ECON, V5, P147, DOI 10.1016/0304-405X(77)90015-0
   Norsk Hydro, 2018, IBAMA LIFTS EMB NEW
   PADDOCK JL, 1988, Q J ECON, V103, P479, DOI 10.2307/1885541
   Pages G, 2004, HDB COMPUTATIONAL NU, P253
   Papoulis A., 2002, PROBABILITY RANDOM V
   Rico M, 2008, J HAZARD MATER, V152, P846, DOI 10.1016/j.jhazmat.2007.07.050
   Sadowsky J, 2005, VALUE LEARNING PRODU
   Savolainen J, 2016, RESOUR POLICY, V50, P49, DOI 10.1016/j.resourpol.2016.08.007
   Schwartz ES, 1997, J FINANC, V52, P923, DOI 10.2307/2329512
   The Church of England, 2019, INV MIN TAIL IN
   Tourinho O., 1979, TECHNICAL REPORT
   TRIGEORGIS L, 1993, FINANC MANAGE, V22, P202, DOI 10.2307/3665939
   Tsekrekos AE, 2012, EUR FINANC MANAG, V18, DOI 10.1111/j.1468-036X.2010.00544.x
   Van Niekerk HJ, 2005, LAND DEGRAD DEV, V16, P201, DOI 10.1002/ldr.681
   Zhao B., 2009, INHOMOGENEOUS GEOMET
NR 65
TC 2
Z9 2
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4207
EI 1873-7641
J9 RESOUR POLICY
JI Resour. Policy
PD OCT
PY 2019
VL 63
AR 101461
DI 10.1016/j.resourpol.2019.101461
PG 15
WC Environmental Studies
SC Environmental Sciences & Ecology
GA JB9FY
UT WOS:000488888100053
DA 2020-12-01
ER

PT J
AU Armstrong, M
   Petter, R
   Petter, C
AF Armstrong, Margaret
   Petter, Renato
   Petter, Carlos
TI Why have so many tailings dams failed in recent years?
SO RESOURCES POLICY
LA English
DT Article
DE Management compensation packages; Bonus system; Put options; Los
   Frailes; Mt Polley; Samarco; Brumadinho; Mining association of Canada
   guidelines
ID ENVIRONMENTAL IMPACTS; COMPENSATION
AB The number of tailings dam failures has doubled in the past 20 years. Advances in mining technology have made it possible to exploit lower grade deposits despite decreasing commodity prices, which means disposing of more rejects and putting more pressure on tailings facilities. Our analysis of four recent tailings dam failures in countries with a strong mining tradition (Los Frailes in Spain, Mt Polley in Canada, Samarco and Brumadinho in Brazil), showed that production had been increased and/or cost cutting measures had been put in place before the accidents. In this paper, we postulate that the compensation packages offered to middle management which actively encourage managers to cut costs and increase production so as to increase their annual bonuses are a key factor in the rising number of serious accidents. Newmont Mining's compensation package contains a component that is equivalent to the options in traders' bonuses. As is well known, this led to excessive risk-taking in banks and hence to the subprime crisis and the global financial crisis. We argue that year after year managers keep taking risks with a low probability of occurrence but with potentially catastrophic consequences. These risks are compounded by shortages of experienced staff due to the cyclic nature of the industry and the retirement of the baby-boomer generation.
C1 [Armstrong, Margaret] Fundacao Getulio Vargas, EMAp Sch Appl Math, Rio De Janeiro, Brazil.
   [Armstrong, Margaret] Univ Adolfo Ibanez, Escuela Negocios, Av Diagonal Torres 2640, Santiago, Chile.
   [Armstrong, Margaret] Univ Chile, Ctr Math Modelling, Santiago, Chile.
   [Petter, Renato; Petter, Carlos] Univ Fed Rio Grande do Sul, Min Engn Dept, Porto Alegre, RS, Brazil.
RP Armstrong, M (corresponding author), Univ Adolfo Ibanez, Escuela Negocios, Av Diagonal Torres 2640, Santiago, Chile.
EM margaret.armstrong171@gmail.com
RI Petter, Carlos/AAE-9945-2019
CR Amnesty International Canada, 2018, IND RIGHTS CONT BE D
   AngloGoldAshanti, 2015, ANG ASH GLOB REM POL
   [Anonymous], 2013, 29 BOL
   [Anonymous], 1998, BOL ANN REP
   [Anonymous], 2017, BOL ANN REP
   [Anonymous], 1997, BOL ANN REP
   [Anonymous], 2012, BOL ANN REP
   [Anonymous], 2002, BOL ANN REP
   [Anonymous], 1999, BOL ANN REP
   [Anonymous], 2014, 30 BOL
   [Anonymous], 2011, BOL ANN REP
   [Anonymous], 2004, BOL ANN REP
   [Anonymous], 2003, BOL ANN REP
   [Anonymous], 2000, BOL ANN REP
   [Anonymous], 2010, BOL ANN REP
   [Anonymous], 2015, 30 BOL
   [Anonymous], 2016, 30 BOL
   Azam Li, 2010, GEOTECHNICAL NEW DEC
   BC Govt, 2015, REP MOUNT POLL TAIL
   BHP, 2017, ANN REP 2017, P126
   Bomey N., 2016, US TODAY
   Bowker LN, 2015, RISK PUBLIC LIABILIT
   Burke LA, 2006, INT J PRODUCT PERFOR, V55, P155, DOI 10.1108/17410400610641726
   Caroli E, 2002, ECON LETT, V77, P21, DOI 10.1016/S0165-1765(02)00095-2
   Caterpillar Viewpoint N&deg; 5, 2014, MIN IND EMPL CREAT S
   Crotty J, 2009, CAMB J ECON, V33, P563, DOI 10.1093/cje/bep023
   Crouhy M, 2008, J DERIVATIVES    FAL, P81
   Davies M, 2002, MINE TAILINGS DAMS T
   Gomes LED, 2017, MAR POLLUT BULL, V120, P28, DOI 10.1016/j.marpolbul.2017.04.056
   Fajardo T, 2014, AZNALCOLLAR KOLONTAR
   Fernandes GW, 2016, NAT CONSERVACAO, V14, P35, DOI 10.1016/j.ncon.2016.10.003
   Greene R, 2003, CISC VIS NETW IND GL
   Harris J, 2007, ORGAN SCI, V18, P350, DOI 10.1287/orsc.1060.0241
   Hatje V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11143-x
   Hoekstra G, 2018, VANCOUVER SUN
   Hull JC, 2017, OPTIONS FUTURES OTHE
   ICOLD, 1995, BULLETIN, V099-1995
   ICOLD, 2001, BULLETIN, V121
   Imperial Metals, 2014, Q REP 1 QUART FIN RE
   Imperial Metals, 2014, Q REP 2 QUART PROD R
   Jones B, 1996, MAIL GUARDIAN N 0322
   JORC, 2018, AUSTR COD REP EXPL R
   Kim K, 2017, J CORP FINANC, V43, P1, DOI 10.1016/j.jcorpfin.2016.12.003
   KIRKPATRICK G, 2009, FINANCIAL MARKET TRE
   Kossoff D, 2014, APPL GEOCHEM, V51, P229, DOI 10.1016/j.apgeochem.2014.09.010
   Lavoie J, 2017, TYEE
   Lawler E.E., 1971, PAY ORG EFFECTIVENES
   Leahy J, 2016, FINANC TIMES
   Martine K, 2018, CIMMAGAZINE     0626
   Minerals Council Australia, 2015, SUBM HOUS REPR STAND
   Opray M, 2016, BHP BILLITONS BRAZIL
   Ramani RV, 2012, PROCEDIA ENGINEER, V46, P9, DOI 10.1016/j.proeng.2012.09.440
   Rico M, 2008, J HAZARD MATER, V152, P846, DOI 10.1016/j.jhazmat.2007.07.050
   Rico M, 2007, FLOODS TAILINGS DAM
   Vale, 2018, S11D EL BAT COMPL
   Van Niekerk HJ, 2005, LAND DEGRAD DEV, V16, P201, DOI 10.1002/ldr.681
   Wise Uranium, 2018, LOS FRAIL TAIL DAM F
   WWF, 2002, MIN DON LESS LEARN
NR 58
TC 7
Z9 7
U1 4
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4207
EI 1873-7641
J9 RESOUR POLICY
JI Resour. Policy
PD OCT
PY 2019
VL 63
AR 101412
DI 10.1016/j.resourpol.2019.101412
PG 11
WC Environmental Studies
SC Environmental Sciences & Ecology
GA JB9FY
UT WOS:000488888100010
DA 2020-12-01
ER

PT J
AU Reus, L
   Pagnoncelli, B
   Armstrong, M
AF Reus, Lorenzo
   Pagnoncelli, Bernardo
   Armstrong, Margaret
TI Better management of production incidents in mining using multistage
   stochastic optimization
SO RESOURCES POLICY
LA English
DT Article
DE Mining incidents; Optimal policy; Stochastic dual dynamic programming;
   Risk-aversion; CVaR; Julia language
ID HARVESTING PROBLEM; PROGRAMMING MODEL; CONDITIONAL VALUE; VALUATION;
   PORTFOLIO; PROJECTS; ASSETS; PRICE
AB Among the many sources of uncertainty in mining are production incidents: these can be strikes, environmental issues, accidents, or any kind of event that disrupts production. In this work, we present a strategic mine planning model that takes into account these types of incidents, as well as random prices. When confronted by production difficulties, mines which have contracts to supply customers have a range of flexibility options including buying on the spot market, or taking material from a stockpile if they have one. Earlier work on this subject was limited in that the optimization could only be carried out for a few stages (up to 5 years) and in that it only analyzed the risk-neutral case. By using decomposition schemes, we are now able to solve large-scale versions of the model efficiently, with a horizon of up to 15 years. We consider decision trees with up to 615 scenarios and implement risk aversion using Conditional Value-at-Risk, thereby detecting its effect on the optimal policy. The results provide a "roadmap" for mine management as to optimal decisions, taking future possibilities into account. We present extensive numerical results using the new sddp.jl library, written in the Julia language, and discuss policy implications of our findings.
C1 [Reus, Lorenzo] Univ Adolfo Ibanez, Fac Ingn & Ciencias, Santiago, Chile.
   [Pagnoncelli, Bernardo; Armstrong, Margaret] Univ Adolfo Ibanez, Escudo Negocios, Santiago, Chile.
   [Armstrong, Margaret] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, Brazil.
   [Armstrong, Margaret] Univ Chile, Ctr Modelamiento Matemat, Santiago, Chile.
RP Reus, L (corresponding author), Univ Adolfo Ibanez, Fac Ingn & Ciencias, Santiago, Chile.
EM lorenzo.reus@uai.cl; bemardo.pagnoncelli@uai.cl;
   margaret.armstrong171@gmail.com
RI Reus, Lorenzo/D-7112-2016
OI Reus, Lorenzo/0000-0001-9171-7688
FU Fondo Nacional de Desarrollo Cientffico y Tecnologico [11170012]; Anillo
   ACTComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT PIA/ANILLOS [1407]; Fondecyt ProjectComision Nacional
   de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT
   [1170178]
FX Lorenzo Reus acknowledges financial support research for this study was
   supported by Fondo Nacional de Desarrollo Cientffico y Tecnologico
   [#11170012]. Bernardo Pagnoncelli thanks Anillo ACT 1407 and Fondecyt
   Project 1170178 for the financial support.
CR Al-Awami AT, 2011, IEEE T SUSTAIN ENERG, V2, P277, DOI 10.1109/TSTE.2011.2111467
   Alonso-Ayuso A, 2014, EUR J OPER RES, V233, P711, DOI 10.1016/j.ejor.2013.08.048
   Amankwah H, 2013, OPTIMIZATION THEORY, P117
   Andersson H., 2007, APPL FINANCIAL EC, V17, P769
   Armstrong M, 2012, T I MIN METALL A, V121, P125, DOI 10.1179/1743286312Y.0000000010
   Armstrong M, 2013, P 36 APCOM S HELD PO
   Arrubla JAG, 2014, INT J WILDLAND FIRE, V23, P825, DOI 10.1071/WF13204
   Artzner P, 1999, MATH FINANC, V9, P203, DOI 10.1111/1467-9965.00068
   Barbarosoglu G, 2004, J OPER RES SOC, V55, P43, DOI 10.1057/palgrave.jors.2601652
   Barrera J, 2016, MATH PROGRAM, V157, P153, DOI 10.1007/s10107-015-0942-x
   Baucke R, 2017, DETERMINISTIC ALGORI
   Beraldi P, 2008, COMPUT OPER RES, V35, P3360, DOI 10.1016/j.cor.2007.03.008
   Birge JR, 2011, SPRINGER SER OPER RE, P3, DOI 10.1007/978-1-4614-0237-4
   Bloomberg, 2011, CYCL YAS SER THREAT
   BRENNAN MJ, 1985, J BUS, V58, P135, DOI 10.1086/296288
   Cantallopts J, 2017, CHILEAN COPPER MININ
   CORTAZAR G, 1993, J BUS, V66, P517, DOI 10.1086/296616
   Cortazar G, 2015, ENERG ECON, V49, P60, DOI 10.1016/j.eneco.2015.01.015
   Cotton TG, 2015, MATH PROGRAM COMPUT, V7, P471, DOI 10.1007/s12532-015-0088-0
   Cuigues V, 2012, EUR J OPER RES, V217, P129, DOI 10.1016/j.ejor.2011.08.017
   Dehghani H, 2014, RESOUR POLICY, V39, P124, DOI 10.1016/j.resourpol.2014.01.003
   Downward A., 2018, STOCHASTIC DUAL DYNA
   Dowson O, 2017, SDDP JL JULIA PACKAG
   Geyer A, 2009, J COMPUT FINANC, V12, P29
   Huang GH, 2000, CIV ENG ENVIRON SYST, V17, P95, DOI 10.1080/02630250008970277
   Hull J.C., 2016, OPTIONS FUTURES OTHE
   Infanger G, 1996, MATH PROGRAM, V75, P241, DOI 10.1007/BF02592154
   Insley M, 2005, AM J AGR ECON, V87, P735, DOI 10.1111/j.1467-8276.2005.00759.x
   KALL P, 2005, INT SER OPER RES MAN, V80, P7
   Kozmik V, 2015, MATH PROGRAM, V152, P275, DOI 10.1007/s10107-014-0787-8
   Krolchmal P., 2002, J RISK, V4, P43, DOI DOI 10.21314/JOR.2002.057
   Lagos G., 2011, ELECT NOTES DISCRETE, V37, P15, DOI [10.1016/j.endm.2011.05.004, DOI 10.1016/J.ENDM.2011.05.004]
   Najafi AA, 2015, APPL MATH COMPUT, V256, P445, DOI 10.1016/j.amc.2015.01.050
   Nogueira M, 2018, EVIDENCE CONTAMINATI
   Norsk Hydro, 2018, FACTS SIT BRAZ
   Ochoa A, 2013, 2013 13TH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS (HIS), P18, DOI 10.1109/HIS.2013.6920479
   PADDOCK JL, 1988, Q J ECON, V103, P479, DOI 10.2307/1885541
   Pagnoncelli BK, 2009, J OPTIMIZ THEORY APP, V142, P399, DOI 10.1007/s10957-009-9523-6
   Pagnoncelli BK, 2017, ANN OPER RES, V258, P479, DOI 10.1007/s10479-015-1963-9
   PEREIRA MVF, 1991, MATH PROGRAM, V52, P359, DOI 10.1007/BF01582895
   Philpott A, 2013, OPER RES, V61, P957, DOI 10.1287/opre.2013.1175
   Rockafellar R, 2000, J RISK, V2, P21, DOI DOI 10.21314/JOR.2000.038
   Rolfe K, 2018, CIM MAGAZINE
   Lasheras FS, 2015, RESOUR POLICY, V45, P37, DOI 10.1016/j.resourpol.2015.03.004
   Savolainen J, 2016, RESOUR POLICY, V50, P49, DOI 10.1016/j.resourpol.2016.08.007
   Schwartz E, 2000, MANAGE SCI, V46, P893, DOI 10.1287/mnsc.46.7.893.12034
   Shapiro A., 2009, LECT STOCHASTIC PROG
   Shapiro A, 2013, EUR J OPER RES, V224, P375, DOI 10.1016/j.ejor.2012.08.022
   Slade ME, 2001, J ENVIRON ECON MANAG, V41, P193, DOI 10.1006/jeem.2000.1139
   SMITH JE, 1995, MANAGE SCI, V41, P795, DOI 10.1287/mnsc.41.5.795
   Smith JE, 1998, OPER RES, V46, P198, DOI 10.1287/opre.46.2.198
   The Local, 2018, NORW NORSK HYDR SPIL
   Thenie J, 2008, AUTOMATICA, V44, P1569, DOI 10.1016/j.automatica.2008.02.001
   Wan Y, 2015, FOREST POLICY ECON, V50, P118, DOI 10.1016/j.forpol.2014.06.002
   Webby RB, 2007, ECOL MODEL, V201, P89, DOI 10.1016/j.ecolmodel.2006.07.033
   Zhang K, 2015, MINER ECON, V28, P11, DOI 10.1007/s13563-014-0048-6
NR 56
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4207
EI 1873-7641
J9 RESOUR POLICY
JI Resour. Policy
PD OCT
PY 2019
VL 63
AR 101404
DI 10.1016/j.resourpol.2019.101404
PG 13
WC Environmental Studies
SC Environmental Sciences & Ecology
GA JB9FY
UT WOS:000488888100004
DA 2020-12-01
ER

PT J
AU Ming, DK
   Armstrong, M
   Lowe, P
   Chiodini, PL
   Doherty, JF
   Whitty, CJM
   McGregor, AC
AF Ming, Damien K.
   Armstrong, Margaret
   Lowe, Patricia
   Chiodini, Peter L.
   Doherty, Justin F.
   Whitty, Christopher J. M.
   McGregor, Alastair C.
TI Clinical and Diagnostic Features of 413 Patients Treated for Imported
   Strongyloidiasis at the Hospital for Tropical Diseases, London
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID STERCORALIS; TRAVELERS; PCR
AB This study describes the clinical features of a cohort of imported cases of strongyloidiasis and the performance of standard diagnostic techniques for this condition. A total of 413 cases were identified, of whom 86 had microscopically proven infection. In proven cases, 23% had normal eosinophil counts, 19% had negative Strongyloides-specific serology, and 9.3% had normal blood counts and were seronegative. Serological testing was less sensitive for returning travelers (46.2%) than for migrants (89.7%). Immunosuppression, including human T-cell lymphotropic virus 1, was significantly associated with proven infection after controlling for age, presence of symptoms, duration of infection, and eosinophilia (OR 5.60, 95% CI 1.54-20.4). Patients with proven infection had lower serology values than those diagnosed with strongyloidiasis on the basis of positive serology and eosinophilia alone (P=0.016). Symptomatic patients were significantly younger, had a shorter presumed duration of infection, and lower serology values. These data suggest a correlation between immunologic control of strongyloidiasis and the amplitude of the humoral response.
C1 [Ming, Damien K.; Armstrong, Margaret; Lowe, Patricia; Chiodini, Peter L.; Doherty, Justin F.; Whitty, Christopher J. M.; McGregor, Alastair C.] Univ Coll Hosp London NHS Fdn Trust, Hosp Trop Dis, London, England.
RP Ming, DK (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6JB, England.
EM damien.ming@doctors.org.uk; margaret.armstrong2@nhs.net;
   patricia.lowe@hslpathology.com; p.chiodini@nhs.net;
   tom.doherty1957@gmail.com; christopher.whitty@lshtm.ac.uk;
   alastair.mcgregor1@nhs.net
FU NIHR Biomedical Research Centres funding scheme
FX This work was undertaken at UCLH/UCL who received a proportion of
   funding from the NIHR Biomedical Research Centres funding scheme. MA was
   supported by the Special Trustees of the Hospital for Tropical Diseases.
CR Buonfrate D, 2015, CLIN MICROBIOL INFEC, V21, P543, DOI 10.1016/j.cmi.2015.04.001
   Buonfrate D, 2015, PLOS NEGL TROP DIS, V9
   Buonfrate D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006229
   Buonfrate D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-78
   Checkley AM, 2010, J INFECTION, V60, P1, DOI 10.1016/j.jinf.2009.11.003
   Dreyer G, 1996, J CLIN MICROBIOL, V34, P2569, DOI 10.1128/JCM.34.10.2569-2571.1996
   Easton AV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1314-y
   GYORKOS TW, 1990, AM J EPIDEMIOL, V132, P257, DOI 10.1093/oxfordjournals.aje.a115655
   Iriemenam NC, 2010, PARASITOL INT, V59, P9, DOI 10.1016/j.parint.2009.10.009
   Llewellyn S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004380
   Lok James B, 2007, WormBook, P1
   Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013
   PELLETIER LL, 1988, J INFECT DIS, V157, P573, DOI 10.1093/infdis/157.3.573
   Pocaterra LA, 2017, AM J TROP MED HYG, V96, P863, DOI 10.4269/ajtmh.16-0414
   Porto AF, 2001, PARASITE IMMUNOL, V23, P503, DOI 10.1046/j.1365-3024.2001.00407.x
   Repetto SA, 2016, ACTA TROP, V157, P169, DOI 10.1016/j.actatropica.2016.02.004
   Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002
   Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707
   Sudarshi S, 2003, TROP MED INT HEALTH, V8, P728, DOI 10.1046/j.1365-3156.2003.01069.x
   Sultana Y, 2013, AM J TROP MED HYG, V88, P1048, DOI 10.4269/ajtmh.12-0437
   Sykes AM, PLOS NEGL TROP DIS, V5, pe955
   Taniuchi M, 2011, AM J TROP MED HYG, V84, P332, DOI 10.4269/ajtmh.2011.10-0461
   ten Hove RJ, 2009, EUR J CLIN MICROBIOL, V28, P1045, DOI 10.1007/s10096-009-0745-1
NR 23
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 2
BP 428
EP 431
DI 10.4269/ajtmh.19-0087
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA IY6WK
UT WOS:000486536800007
PM 31219002
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Armstrong, M
   Petter, R
   Petter, C
AF Armstrong, Margaret
   Petter, Renato
   Petter, Carlos
TI Going Viral: How attacks in social media can erode confidence in mining.
   The Samarco-yellow fever example from Brazil
SO RESOURCES POLICY
LA English
DT Article
DE Environmental; Vale; BHP Billiton; Renova; Directed networks; Social
   acceptability of mining
ID LICENSE; EVOLUTION; NETWORK; OPERATE
AB The Samarco tailings dam broke on 5 November 2015, sending a wall of mud into the Bento Rodrigues township and killing 19 people. From there the mud made its way to the Rio Doce river system, killing fish and frogs, and causing massive pollution down to the mouth 650 km away. A year later a yellow fever outbreak occurred in the same state in Brazil, with 450 confirmed cases and about 150 deaths. After newspapers reported the yellow fever cases, online blogs started suggesting that the outbreak might have been caused by the Samarco disaster and citing comments by well-known scientists. Twelve months later another yellow fever outbreak occurred, and the online bloggers repeated the same claims, but the wording changed.
   In this paper we analyze the timing of the online activity, using Google search to find all the postings in the press and in social media with the two terms, "Samarco" and "Febre Amarela" (yellow fever, in Portuguese). In 2017, most postings faithfully reported what the scientists had said, but in 2018, some postings started making stronger claims than the scientists originally had. After analyzing the content of the postings, we construct two directed networks, one for 2017 and the other for 2018, to show to which scientists the postings refer and to illustrate the subtle and not so subtle distortions that started to creep in. In the conclusion we ask how the rise in hostility to mining expressed in some of these blogs should be interpreted. Is it just the usual low-level dislike of the extractive industries or are these the precursor symptoms of a more general refusal to accept mining in Brazil?
C1 [Armstrong, Margaret] Fundacao Getulio Vargas, EMAp Sch Appl Math, 190 Praia Botafogo, BR-22250900 Rio De Janeiro, RJ, Brazil.
   [Armstrong, Margaret] PSL Res Univ, CERNA Ctr Ind Econ, MINES Paristech, i3,CNRS UMR 9217, Paris, France.
   [Petter, Renato; Petter, Carlos] Univ Fed Rio Grande do Sul, Min Engn Dept, Porto Alegre, RS, Brazil.
RP Armstrong, M (corresponding author), Fundacao Getulio Vargas, EMAp Sch Appl Math, 190 Praia Botafogo, BR-22250900 Rio De Janeiro, RJ, Brazil.
EM margaret.armstrong@fgv.br
RI Petter, Carlos/AAE-9945-2019
OI Petter, Renato/0000-0003-2479-2527
CR Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48
   [Anonymous], 2017, ABC NEWS
   [Anonymous], 2018, BBC NEWS
   Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   BBC, 2016, BBC NEWS
   Bloomberg, 2018, ENV DIS CHANG BRAZ M
   Correa LB., 2017, MARINE POLLUTION B, V120, P28, DOI [10.1016/j.marpolbul.2017.04.056., DOI 10.1016/J.MARPOLBUL.2017.04.056]
   Erdos P., 1960, PUBL MATH I HUNG, V5, P17, DOI DOI 10.2307/1999405
   Farrell J, 2016, NAT CLIM CHANGE, V6, P370, DOI [10.1038/NCLIMATE2875, 10.1038/nclimate2875]
   Fernandes GW, 2016, NAT CONSERVACAO, V14, P35, DOI 10.1016/j.ncon.2016.10.003
   Fiocruz, 2017, REV RADIS
   Formenti L, 2017, BIOL SURTO FEBRE AMA
   GALINDO PEDRO, 1955, ANN ENT SOC AMER, V48, P158
   Globo, 2018, IB MULT ANGL AM MAIS
   Hatje V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11143-x
   Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007
   Hydro, 2018, FACTS SIT BRAZ
   IBAMA, 2009, REL AC AM 2009
   Koniaris M, 2018, J COMPLEX NETW, V6, P243, DOI 10.1093/comnet/cnx029
   LeDuc J. W., 1989, REV INFECT DIS S4, V11, DOI [10.1093/clinids/11.Supplement_4.S730, DOI 10.1093/CLINIDS/11.SUPPLEMENT_4.S730]
   Luca C., 2018, REGAIN TRUST ALIGNIN, P14
   Moreno JL, 1938, SOCIOMETRY, V1, P342, DOI 10.2307/2785588
   Oliveira R., 2018, TRAS VERDADEIRA MECA
   Opray M., BHP BILLITONS BRAZIL
   Owen JR, 2013, RESOUR POLICY, V38, P29, DOI 10.1016/j.resourpol.2012.06.016
   Papachristos AV, 2009, AM J SOCIOL, V115, P74, DOI 10.1086/597791
   Prno J, 2012, RESOUR POLICY, V37, P346, DOI 10.1016/j.resourpol.2012.04.002
   Reuters, 2018, EVIDENCE CONTAMINATI
   Santos P., 2017, PROFESSOR UFOP DESCA
   Santos R. S. P., 2017, VIBRANT-VIRTUAL BRAZ, V14, P2
   Slack K, 2012, RESOUR POLICY, V37, P179, DOI 10.1016/j.resourpol.2011.02.003
   Suarez J., 2017, SURTO FEBRE AMARELA
   The Local, 2018, NORW NORSK HYDR SPIL
   Thomson I., 2011, SME MINING ENG HDB, P673
   Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474
   Vale, 2017, ANN REPORT, P152
   Vale, 2017, ANN REPORT, P151
   Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825
   Zhang AR, 2015, J CLEAN PROD, V108, P1063, DOI 10.1016/j.jclepro.2015.07.097
NR 41
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4207
EI 1873-7641
J9 RESOUR POLICY
JI Resour. Policy
PD DEC
PY 2018
VL 59
SI SI
BP 340
EP 350
DI 10.1016/j.resourpol.2018.08.006
PG 11
WC Environmental Studies
SC Environmental Sciences & Ecology
GA HG4WE
UT WOS:000454974900034
DA 2020-12-01
ER

PT J
AU Hunter, E
   Cliff, M
   Armstrong, M
   Manji, H
   Jager, HR
   Chiodini, P
   Brown, M
AF Hunter, Ewan
   Cliff, Michael
   Armstrong, Margaret
   Manji, Hadi
   Jager, Hans Rolf
   Chiodini, Peter
   Brown, Mike
TI Active neurocysticercosis at the Hospital for Tropical Diseases, London:
   a clinical case series
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE albendazole; England; praziquantel; seizures; Taenia solium; transients
   and migrants
ID LINKED IMMUNOELECTROTRANSFER BLOT; CYSTICERCOSIS TAENIA-SOLIUM;
   DIAGNOSTIC-CRITERIA; UNITED-STATES; EITB ASSAY; EUROPE; PRAZIQUANTEL;
   METAANALYSIS; INFECTIONS; GRANULOMA
AB Background: Neurocysticercosis is the commonest infectious cause of epilepsy in endemic countries, and accounts for a greater number of cases worldwide than any other single pathology. Infection is associated with long-term exposure in low-income countries, although acquisition after travel has been recognized. The standard of care in the UK is inpatient treatment with anti-helminthic drugs and steroids.
   Methods: The authors reviewed all cases of neurocysticercosis managed at the Hospital for Tropical Diseases in London, England, between 2001 and 2015. Active disease was defined as evidence of either viable cysts or involuting cysts with associated parenchymal inflammation.
   Results: Of 26 active cases, 65.4% were migrants from nine different countries; 34.6% were UK-born travellers who had visited 19 countries across South and Central America, sub-Saharan Africa, South and South-east Asia; India was the commonest country of exposure in both groups. Only 73.1% presented with seizures; two diagnoses were made through brain imaging of patients with peripheral cysticerci; 53.8% had a single cyst. Migrants were more likely to be seropositive than travellers (p=0.033). Only two patients had seizures during admission, one of whom had multiple seizures prior to diagnosis.
   Conclusions: Neurocysticercosis presents in a non-endemic setting in both migrants and travellers. Travellers are less likely to be sero-positive. Not all cases of neurocysticercosis present with seizures. Outpatient management could be considered for selected patients.
C1 [Hunter, Ewan; Armstrong, Margaret; Chiodini, Peter; Brown, Mike] Univ Coll Hosp, Hosp Trop Dis, London, England.
   [Hunter, Ewan; Chiodini, Peter; Brown, Mike] London Sch Hyg & Trop Med, London, England.
   [Cliff, Michael] Univ Coll Hosp, London, England.
   [Manji, Hadi] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Dept Mol Neurosci, Queen Sq, London, England.
   [Jager, Hans Rolf] UCL Inst Neurol, Acad Neuroradiol Unit, Dept Brain Repair & Rehabil, London, England.
   [Hunter, Ewan] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
RP Hunter, E (corresponding author), Univ Coll Hosp, Hosp Trop Dis, London, England.; Hunter, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Hunter, E (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
EM ewan.hunter@nuth.nhs.uk
RI Hunter, Ewan/AAQ-7925-2020
FU National Institute for Health Research University College London
   Hospitals Biomedical Research Centre
FX PLC is supported by the National Institute for Health Research
   University College London Hospitals Biomedical Research Centre.
CR ALLCUT DA, 1991, J NEUROL NEUROSUR PS, V54, P461, DOI 10.1136/jnnp.54.5.461
   Bhalla Ashish, 2008, J Med Case Rep, V2, P137, DOI 10.1186/1752-1947-2-137
   Booker Matthew J, 2008, Cases J, V1, P104, DOI 10.1186/1757-1626-1-104
   Bruschi F, 2006, Pathologica, V98, P229
   Carpio A, 2016, ANN NEUROL, V80, P434, DOI 10.1002/ana.24732
   Coyle CM, 2009, INTERDISCIP PERSPECT, V2009, P9
   Cuello-Garcia CA, 2013, INT J INFECT DIS, V 17, pE583, DOI 10.1016/j.ijid.2012.12.010
   Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025
   Del Brutto OH, 2012, ACTA NEUROL BELG, V112, P335, DOI 10.1007/s13760-012-0068-3
   Devleesschauwer B, 2017, ACTA TROP, V165, P96, DOI 10.1016/j.actatropica.2015.08.006
   DIAZ F, 1992, AM J EPIDEMIOL, V135, P875, DOI 10.1093/oxfordjournals.aje.a116383
   DIAZ JF, 1992, AM J TROP MED HYG, V46, P610, DOI 10.4269/ajtmh.1992.46.610
   Dixon HBF, 1962, P ROY SOC MED, V55, P242
   Fabiani S, 2013, ACTA TROP, V128, P18, DOI 10.1016/j.actatropica.2013.06.020
   FERRANTE L, 1985, ACTA NEUROCHIR, V76, P28, DOI 10.1007/BF01403826
   Mont'Alverne FEF, 2011, ARQ NEURO-PSIQUIAT, V69, P74, DOI 10.1590/S0004-282X2011000100015
   Furrows SJ, 2006, CLIN MICROBIOL INFEC, V12, P459, DOI 10.1111/j.1469-0691.2006.01381.x
   Garcia HH, 2014, EPILEPSIA, V55, P1452, DOI 10.1111/epi.12739
   Garcia HH, 2014, LANCET INFECT DIS, V14, P687, DOI 10.1016/S1473-3099(14)70779-0
   Hortobagyi T, 2009, PATHOL ONCOL RES, V15, P143, DOI 10.1007/s12253-008-9098-9
   Hotez PJ, 2011, INT J INFECT DIS, V15, pE611, DOI 10.1016/j.ijid.2011.05.006
   Kassar H, 2014, EUR J PUBLIC HEALTH, V24, P2, DOI 10.1093/eurpub/cku105
   Kobayashi K, 2013, AM J TROP MED HYG, V89, P58, DOI 10.4269/ajtmh.12-0355
   Laranjo-Gonzalez M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2280-8
   Marks M, 2016, T ROY SOC TROP MED H, V110, P456, DOI 10.1093/trstmh/trw053
   Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870
   O'Neal SE, 2015, EMERG INFECT DIS, V21, P969, DOI 10.3201/eid2106.141324
   Otte WM, 2013, NEUROLOGY, V80, P152, DOI 10.1212/WNL.0b013e31827b90a8
   Pellegrino A, 2004, IOM MIGRATION RES SE
   Rajshekhar V, 1997, ACTA NEUROL SCAND, V96, P76
   Rao KRS, 2003, ARCH DIS CHILD, V88, P471, DOI 10.1136/adc.88.6.471
   SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004
   Serpa JA, 2011, MEDICINE, V90, P81, DOI 10.1097/MD.0b013e318206d13e
   Sorvillo F, 2011, EMERG INFECT DIS, V17, P1, DOI 10.3201/eid1701.101210
   TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50
   White AC, 2018, CLIN INFECT DIS, V66, pE49, DOI 10.1093/cid/cix1084
   WILSON M, 1991, J INFECT DIS, V164, P1007, DOI 10.1093/infdis/164.5.1007
   Zammarchi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069537
   Zhao BC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004418
NR 39
TC 5
Z9 5
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL
PY 2018
VL 112
IS 7
BP 326
EP 334
DI 10.1093/trstmh/try060
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GZ8IC
UT WOS:000449731900003
PM 29982795
DA 2020-12-01
ER

PT J
AU dos Santos, BMC
   Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coimbra dos Santos, Beatriz Macedo
   Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Zika: an ongoing threat to women and infants
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Zika Virus; Women; Child; Incidence
ID SEXUAL TRANSMISSION; VIRUS; BRAZIL
AB Recent data from the municipality of Rio de Janeiro, Brazil, shows a sharp drop in the number of reported occurrences of Zika during the summer of 2016/2017 compared to the previous summer. There is still a much higher incidence among women than men, almost certainly due to sexual transmission. An unexpected feature of the new data is that there are proportionally far more cases affecting children under 15 months than older age classes. By comparing incidence rates in 2016/2017 and 2015/2016, we were able to deduce the proportion of reported cases affecting men and women, and verify that gender disparity is still present. Women and children are still risk groups for Zika infection, even during non-epidemic seasons.
C1 [Coimbra dos Santos, Beatriz Macedo; Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
RP dos Santos, BMC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
EM beatrizmcoimbra@outlook.com
CR Bastos Maria do Ceu, 2018, THESIS
   Codeco C, 2016, BIORXIV
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Freour T., 2016, EURO SURVEILL, V21
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pacheco O, 2016, N ENGL J MED
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 14
TC 2
Z9 2
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 11
AR e00038218
DI 10.1590/0102-311X00038218
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF0TG
UT WOS:000453875600001
PM 30427409
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU dos Santos, BMC
   Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coimbra dos Santos, Beatriz Macedo
   Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Reply to commentary on Zika: An Ongoing Threat to Women and Infants
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Coimbra dos Santos, Beatriz Macedo; Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
RP dos Santos, BMC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, BR-22250900 Rio De Janeiro, RJ, Brazil.
EM beatrizmcoimbra@outlook.com
CR Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Barros AC, 2018, 347104 BIORXIV, DOI [10.1101/347104, DOI 10.1101/347104]
   de Azevedo MB, 2018, REV SOC BRAS MED TRO, V51, P347, DOI 10.1590/0037-8682-0327-2017
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 11
AR e00192318
DI 10.1590/0102-311X00192318
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HF0UN
UT WOS:000453879300001
PM 30427419
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Amaku, M
   Coutinho, FAB
   Armstrong, M
   Massad, E
AF Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Armstrong, Margaret
   Massad, Eduardo
TI A Note on the Risk of Infections Invading Unaffected Regions
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article
ID TRAVEL; STRATEGIES; EPIDEMIC; MODELS; VIRUS; ZIKA
AB We present two probabilistic models to estimate the risk of introducing infectious diseases into previously unaffected countries/regions by infective travellers. We analyse two distinct situations, one dealing with a directly transmitted infection (measles in Italy in 2017) and one dealing with a vector-borne infection (Zika virus in Rio de Janeiro, which may happen in the future). To calculate the risk in the first scenario, we used a simple, nonhomogeneous birth process. The second model proposed in this paper provides a way to calculate the probability that local mosquitoes become infected by the arrival of a single infective traveller during his/her infectiousness period. The result of the risk ofmeasles invasion of Italy was of 93% and the result of the risk of Zika virus invasion of Rio de Janeiro was of 22%.
C1 [Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Massad, Eduardo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Armstrong, Margaret; Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Univ Derby, Coll Nat & Life Sci, Derby, England.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
RP Amaku, M (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
EM amaku@usp.br
RI Amaku, Marcos/D-5252-2012; Massad, Eduardo/B-1169-2012
OI Amaku, Marcos/0000-0003-4752-6774; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [LIM01-HCFMUSP]; Brazilian Ministry of Health [777588/2012]; ZikaPLAN
   through the European Union's Horizon 2020 Research and Innovation
   Programme [734584]; Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus ProgramCanadian
   Institutes of Health Research (CIHR) [372512]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (Grant no. 777588/2012), by ZikaPLAN through the
   European Union's Horizon 2020 Research and Innovation Programme (Grant
   no. 734584), and the Canadian Institutes of Health Research (CIHR),
   Consortium Canada-Latin/America-Caribean Zika Virus Program (Grant no.
   372512).
CR Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   ANDERSON R M, 1991
   Bailey NT, 2006, ELEMENTS STOCHASTIC
   Bossak BH, 2009, MED HYPOTHESES, V72, P749, DOI 10.1016/j.mehy.2008.12.045
   Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143
   ECDC, 2018, MEASL EU EEA CURR OU
   European Asylum Support Office(EASO), LAT AS TRENDS
   Gomes M. F. C., 2014, PLOS CURRENTS, DOI [10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5, 10.1371/currents.outbreaks]
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2004, MED HYPOTHESES, V63, P911, DOI 10.1016/j.mehy.2004.03.028
   Massad E, 2007, MED HYPOTHESES, V68, P442, DOI 10.1016/j.mehy.2006.07.041
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2010, MEM I OSWALDO CRUZ, V105, P179, DOI 10.1590/S0074-02762010000200012
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Stannard David E., 1993, P35, DOI 10.1017/CHOL9780521332866.006
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   UNWTO. World, 2018, TOUR ORG NEWS, V9
   van den Broek J, 2007, BIOSTATISTICS, V8, P453, DOI 10.1093/biostatistics/kxl023
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Voice of Europe, 2018, MOR 5 MILL 3 WORLD I
   Wilder-Smith A, 2003, J TRAVEL MED, V10, P257
   Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004
NR 28
TC 1
Z9 1
U1 0
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2018
AR 6289681
DI 10.1155/2018/6289681
PG 8
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GN2XK
UT WOS:000438865600001
PM 30073032
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Coelho, FC
   Armstrong, M
   Saraceni, V
   Lemos, C
AF Coelho, Flavio Codeco
   Armstrong, Margaret
   Saraceni, Valeria
   Lemos, Cristina
TI Can Zika Account for the Missing Babies?
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE Zika; sexually transmitted diseases; infant; newborn; diseases; live
   birth rate; epidemiology
ID VIRUS
AB The Zika virus (ZIKV) spread rapidly in Brazil in 2015 and 2016. Rio de Janeiro was among the Brazilian cities which were hit the hardest, with more that a hundred thousand confirmed cases up to the end of 2016. Given the severity of the neurological damage caused by ZIKV on fetuses, we wondered whether it would also cause an increase in the number of miscarriages, especially very early ones. As early miscarriages are unlikely to be recorded as a health event, this effect-if it occurred-would only show up as a reduction in the number of live births. In this article, we show that there was a 15% drop in live births between September and December 2016 compared with the previous year, and that this sharp drop from epidemiological week 33 onward is strongly correlated with the number of recorded cases of Zika about 40 weeks earlier. We postulate that ZIKV is directly responsible for this drop in the birth rate. Further work is required to ascertain whether other factors such as the fear of having a microcephaly baby or the economic crisis are having a significant effect.
C1 [Coelho, Flavio Codeco; Armstrong, Margaret] Fundacao Getulio Vargas, Ctr Math Epidemiol, Sch Appl Math, Brasilia, DF, Brazil.
   [Saraceni, Valeria; Lemos, Cristina] Prefeitura Cidade Rio de Janeiro, Rio De Janeiro, Brazil.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Ctr Math Epidemiol, Sch Appl Math, Brasilia, DF, Brazil.
EM fccoelho@fgv.br
RI Coelho, Flavio Codeco/L-1089-2018
OI Coelho, Flavio Codeco/0000-0003-0635-8989
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Coelho FC, 2016, BIORXIV, DOI 10.1101/055459
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
NR 9
TC 3
Z9 3
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD NOV 29
PY 2017
VL 5
AR 317
DI 10.3389/fpubh.2017.00317
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FO7ZJ
UT WOS:000417099200001
PM 29238705
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Gaskell, KM
   Burke, R
   Armstrong, M
   Lockwood, D
AF Gaskell, Katherine M.
   Burke, Rachael
   Armstrong, Margaret
   Lockwood, Diana
TI A RETROSPECTIVE REVIEW OF THE HOSPITAL FOR TROPICAL DISEASES
   LEISHMANIASIS CASES IN 2013-2015
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Gaskell, Katherine M.; Burke, Rachael; Armstrong, Margaret; Lockwood, Diana] Hosp Trop Dis, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 518
BP 163
EP 163
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502041
DA 2020-12-01
ER

PT J
AU Barrett, J
   Warrell, CE
   Macpherson, L
   Watson, J
   Lowe, P
   Armstrong, M
   Whitty, CJM
AF Barrett, Jessica
   Warrell, Clare E.
   Macpherson, Liana
   Watson, Julie
   Lowe, Patricia
   Armstrong, Margaret
   Whitty, Christopher J. M.
TI The changing aetiology of eosinophilia in migrants and returning
   travellers in the Hospital for Tropical Diseases, London 2002-2015: An
   observational study
SO JOURNAL OF INFECTION
LA English
DT Article
DE Eosinophilia; Parasites; Strongyloides; Aetiology; Travellers
ID IMPORTED EOSINOPHILIA; GLOBAL PROGRAM; REFUGEES; SCHISTOSOMIASIS;
   IMMIGRANTS; FILARIASIS; STRONGYLOIDIASIS; RECOMMENDATIONS; MANAGEMENT;
   INFECTION
AB Introduction: Determining the cause of eosinophilia in patients returning from the tropics continues to present a diagnostic challenge. The history, symptoms and degree of eosinophilia are often poor predictors of eventual diagnosis, but helminths are an important cause. The current British Infection Association recommendations use travel history to guide investigation of eosinophilia. However the global burden of helminth disease and travel patterns have changed over the last 3 decades and guidelines based on previous epidemiology need to be reviewed in the light of current data.
   Methods: Consecutive patients presenting with, or referred for, investigation of eosinophilia were identified prospectively. Case notes, laboratory results and electronic records were reviewed for demographic and clinical data. Patients with an eosinophil count >= 0.50 x 10(9)/L were included, and grouped based on lifetime history of travel to: West Africa, elsewhere in Africa, and the rest of the world. Results were compared to published data from 1997 to 2002 collected at the same centre.
   Results: Of 410 patients who met the inclusion criteria, 407 had a documented travel history. Average yearly referrals for eosinophilia fell from 58 per year between 1997 and 2002, to 33 per year (2002-2015). The proportion of eosinophilia cases diagnosed with a parasitic cause fell from 64% to 50%, and yields for all parasitological investigations fell, the largest reduction in stool microscopy (20% yield to 9%) and day bloods for microfilariae (14% yield to 3%). Strongyloides stercoralis was the commonest diagnosis overall in our cohort, accounting for 50% of the total parasites diagnosed, and was present in 38% of patients from West Africa, 19% from rest of Africa, and 34% from rest of world; a relative increase compared to previous data. Schistosomiasis is slightly less common in those who had travelled to West Africa than the rest of Africa, and overall point prevalence has fallen from 33% (1997-2002) to 17% (2002-2015). Travellers were significantly less likely than patients who had immigrated to the UK to be diagnosed with any parasite (OR 0.54 95% CI 0.378-0.778 p = 0.0009).
   Discussion: A parasitic cause will still be found in half of people returning from the tropics with an eosinophilia, but we observed a fall in the overall prevalence of parasitic diagnoses when compared with the earlier data. This may, in part, be explained by the impact of control programmes on the prevalence of parasites globally, especially filarial disease. S. stercoralis now represents the majority of parasites diagnosed in our cohort from all continents. We identified significantly higher rates of strongyloidiasis in immigrants than returning travellers. Despite the falling yields of stool microscopy and filarial serology the current guidelines based on travel history remain relevant with adequate yield. (C) 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Barrett, Jessica; Warrell, Clare E.; Macpherson, Liana] Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Euston Rd, London, England.
   [Watson, Julie; Lowe, Patricia] Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Dept Parasitol, London, England.
   [Armstrong, Margaret] Univ Coll London Hosp NHS Trust, London, England.
   [Whitty, Christopher J. M.] Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Infect Dis & Trop Med, London, England.
RP Barrett, J (corresponding author), Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Euston Rd, London, England.
EM jessica.barrett@gstt.nhs.uk; c.warrell@nhs.net; lianamacpherson@nhs.net;
   Margaret.armstrong@uclh.nhs.uk; Christopher.whitty@lshtm.ac.uk
CR Baaten GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-84
   Belhassen-Garcia M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000043
   Butt NM, 2017, BRIT J HAEMATOL, V176, P553, DOI 10.1111/bjh.14488
   Garcia-Otero EC, 2016, ENFERM INFEC MICR CL, V34, P661, DOI 10.1016/j.eimc.2016.10.007
   Centers for Disease Control and Prevention, GUID OV PRES TREATM
   Centers for Disease Control and Prevention, INT PAR DOM MED EX N
   Checkley AM, 2010, J INFECTION, V60, P1, DOI 10.1016/j.jinf.2009.11.003
   Dawson-Hahn EE, 2010, J PEDIATR-US, V156, P1016, DOI 10.1016/j.jpeds.2010.02.043
   Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a
   LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353
   Meltzer E, 2008, AM J TROP MED HYG, V78, P702, DOI 10.4269/ajtmh.2008.78.702
   Molinier S, 1998, Med Trop (Mars), V58, P499
   Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374
   Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006
   Naidu P, 2013, CAN J INFECT DIS MED, V24, P93, DOI 10.1155/2013/290814
   NUTMAN TB, 1987, J INFECT DIS, V155, P309, DOI 10.1093/infdis/155.2.309
   O'Brien DP, 2006, J TRAVEL MED, V13, P145, DOI 10.1111/j.1708-8305.2006.00033.x
   Pardo J, 2006, EMERG INFECT DIS, V12, P1587, DOI 10.3201/eid1210.060102
   Posey DL, 2007, CLIN INFECT DIS, V45, P1310, DOI 10.1086/522529
   Salas-Coronas J, 2017, REV ESP QUIM, V30, P62
   Salas-Coronas J, 2015, TRAVEL MED INFECT DI, V13, P315, DOI 10.1016/j.tmaid.2015.04.004
   Samba E.M., 1994, ONCHOCERCIASIS CONTR
   Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026
   Serre-Delcor N, 2016, ENFERM INFECC MICROB, V2016
   Seybolt LM, 2006, CLIN INFECT DIS, V42, P363, DOI 10.1086/499238
   Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707
   Turner HC, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0147-4
   Whetham J, 2003, J INFECTION, V46, P180, DOI 10.1053/jinf.2002.1108
NR 28
TC 5
Z9 5
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD OCT
PY 2017
VL 75
IS 4
BP 301
EP 308
DI 10.1016/j.jinf.2017.08.007
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FM6BQ
UT WOS:000415131400003
PM 28842188
DA 2020-12-01
ER

PT J
AU Lampejo, T
   Lambourne, J
   Armstrong, M
   Checkley, AM
   Nastouli, E
AF Lampejo, Temi
   Lambourne, Jonathan
   Armstrong, Margaret
   Checkley, Anna M.
   Nastouli, Eleni
TI Epstein-Barr virus and cytomegalovirus mononucleosis: Important causes
   of febrile illness in returned travellers
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Epstein-Barr virus; Cytomegalovirus; Mononucleosis; Fever; Returning
   traveller
ID INFECTIOUS-MONONUCLEOSIS; CONGENITAL CYTOMEGALOVIRUS; DIAGNOSIS; BURDEN
AB Background: Diagnosing the cause of fever in the returned traveller is challenging. Efforts often focus on identifying 'exotic' pathogens. Primary Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections cause clinical features that overlap with many exotic pathogens. The age-matched seroprevalence of both EBV and CMV is greater in tropical than temperate areas. We describe the clinical and laboratory features of returned travellers diagnosed with primary CMV and EBV syndromes.
   Methods: Patients with laboratory-confirmed primary EBV and CMV infections who had attended the Hospital for Tropical Diseases (HTD), London between 1st October 2011 and 1st October 2016 were identified. Clinical and laboratory data were obtained and analysed.
   Results: Twenty-two patients with primary EBV infection and 31 with primary CMV infection were identified. The commonest presenting features of both infections were fever (81.1%), headache (50.9%) and arthralgia/myalgia (49.1%). Cervical lymphadenopathy was seen more frequently with EBV than with CMV (59.1% vs. 25.8%, P = 0.02). Transaminitis (79.2%) and lymphocytosis (52.8%) were the commonest laboratory abnormalities in both groups.
   Conclusions: Primary EBV and CMV infections are important causes of febrile illness in returning travellers. Identification of these pathogens prevents unnecessary, expensive investigations for more 'exotic' pathogens and impacts clinical management for example facilitating prognostication and antimicrobial stewardship. Crown Copyright (C) 2017 Published by Elsevier Ltd. All rights reserved.
C1 [Lampejo, Temi; Armstrong, Margaret; Checkley, Anna M.; Nastouli, Eleni] Univ Coll London Hosp NHS Fdn Trust, London, England.
   [Lambourne, Jonathan] Royal London Hosp, Div Infect, 80 Newark St, London E1 2ES, England.
RP Lampejo, T (corresponding author), Univ Coll London Hosp NHS Fdn Trust, London, England.
EM tlampejo@gmail.com
RI Lampejo, Temi/AAW-9095-2020
OI Lampejo, Temi/0000-0002-7652-4236
CR Bartlett A, 2016, INJURY, V47, P531, DOI 10.1016/j.injury.2015.10.071
   Becker JA, 2014, SPORTS HEALTH, V6, P232, DOI 10.1177/1941738114521984
   Boppana S, 2007, HUM HERPESVIRUSES BI
   Bottieau E, 2006, J TRAVEL MED, V13, P191, DOI 10.1111/j.1708-8305.2006.00049.x
   Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655
   Carvalho-Queiroz C, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00093
   De Paschale Massimo, 2012, World J Virol, V1, P31, DOI 10.5501/wjv.v1.i1.31
   Fourcade G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175574
   HAUTEKEETE ML, 1995, ACTA GASTRO-ENT BELG, V58, P290
   KANGRO HO, 1982, J MED VIROL, V10, P203, DOI 10.1002/jmv.1890100306
   Lang DT, 2001, CLIN DIAGN LAB IMMUN, V8, P747, DOI 10.1128/CDLI.8.4.747-756.2001
   Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x
   Ludwig A, 2009, EUROSURVEILLANCE, V14, P26
   Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Mellinger JL, 2014, DIGEST DIS SCI, V59, P1630, DOI 10.1007/s10620-014-3029-2
   Onodi-Nagy K, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/1710-1492-11-1
   Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47
   Revello MG, 2002, J INFECT DIS, V186, P553, DOI 10.1086/341831
   Robertson P, 2003, J MED VIROL, V70, P617, DOI 10.1002/jmv.10439
   SCHMITZ H, 1985, LANCET, V2, P503
   Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173
   Yu YD, 2013, SURG TODAY, V43, P424, DOI 10.1007/s00595-012-0209-6
NR 23
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP
PY 2017
VL 19
BP 28
EP 32
DI 10.1016/j.tmaid.2017.09.006
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FN3HY
UT WOS:000415890000006
PM 28943374
DA 2020-12-01
ER

PT J
AU Coelho, FC
   Durovni, B
   Saraceni, V
   Lemos, C
   Codeco, CT
   Camargo, S
   de Carvalho, LM
   Bastos, L
   Arduini, D
   Villela, DAM
   Armstrong, M
AF Coelho, Flavio Codeco
   Durovni, Betina
   Saraceni, Valeria
   Lemos, Cristina
   Codeco, Claudia Torres
   Camargo, Sabrina
   de Carvalho, Luiz Max
   Bastos, Leonardo
   Arduini, Denise
   Villela, Daniel A. M.
   Armstrong, Margaret
TI Higher incidence of Zika in adult women than adult men in Rio de Janeiro
   suggests a significant contribution of sexual transmission from men to
   women
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Sexual transmission; Dengue; Age-adjusted incidence
ID POTENTIAL VECTOR; VIRUS; DENGUE
AB Objectives: The recent emergence of Zika in Brazil and its association with an increased rate of congenital malformations has raised concerns over its impact on the birth rate in the country. Using data on the incidence of Zika in 2015-2016 and dengue in 2013 and 2015-2016 for the city of Rio de Janeiro (population 6.4 million), a massive increase of Zika in women compared to men was documented.
   Methods: The age-adjusted incidence was compared between men and women. A negative binomial Poisson generalized linear model was fitted to the Zika incidence data to determine the significance of sexual transmission statistically.
   Results: Even after correcting for the bias due to the systematic testing of pregnant women for Zika, there were found to be 90% more registered cases per 100 000 women than men in the sexually active age group (15-65 years); this was not the case for age groups < 15 years and > 65 years. Assuming that infected men transmit the disease to women in their semen, but that the converse is not true, some extra incidence in women is to be expected. An alternate hypothesis would be that women visit doctors more often than men. To test this, the incidence of dengue fever was compared in men and women in 2015 and in 2013 (before Zika reached Rio de Janeiro): in both years, women were 30% more likely to be reported with dengue.
   Conclusion: Women in the sexually active age group are far more likely to get Zika than men (+ 90% increase); sexual transmission is the most probable cause. Women in the 15-65 years age group are also 30% more likely to be reported with dengue than men, which is probably due to women being more careful with their health. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Coelho, Flavio Codeco; Camargo, Sabrina; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, Rio De Janeiro, Brazil.
   [Durovni, Betina; Saraceni, Valeria; Lemos, Cristina; Arduini, Denise] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
   [Codeco, Claudia Torres; de Carvalho, Luiz Max; Bastos, Leonardo; Villela, Daniel A. M.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.
   [de Carvalho, Luiz Max] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Armstrong, Margaret] PSL Res Univ, MINES Paristech, CERNA Ctr Ind Econ, I3,CNRS UMR 9217, Paris, France.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, Rio De Janeiro, Brazil.
EM fccoelho@fgv.br
RI Carvalho, Luiz Max F/J-6446-2014; Camargo, Sabrina/AAH-4857-2020;
   Carvalho, Luiz Max/AAC-8266-2020; Bastos, Leonardo Soares/AAD-5335-2019;
   Camargo, Sabrina/J-3745-2013; amsalu, ribka/G-8780-2019; Coelho, Flavio
   Codeco/L-1089-2018; Villela, Daniel/AAG-6445-2019; Coelho,
   Flavio/L-1089-2018
OI Carvalho, Luiz Max F/0000-0001-5736-5578; Camargo,
   Sabrina/0000-0002-0237-3535; Carvalho, Luiz Max/0000-0001-5736-5578;
   Bastos, Leonardo Soares/0000-0002-1406-0122; Camargo,
   Sabrina/0000-0002-0237-3535; Coelho, Flavio Codeco/0000-0003-0635-8989;
   Villela, Daniel/0000-0001-8371-2959; Coelho, Flavio/0000-0003-3868-4391
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kassam Ashifa, 2015, GUARDIAN
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 14
TC 77
Z9 79
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 128
EP 132
DI 10.1016/j.ijid.2016.08.023
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700031
PM 27664930
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Takaoka, K
   Gourtsoyannis, Y
   Hart, JD
   Armstrong, M
   Daniel, A
   Mewse, E
   Phillips, D
   Bailey, RL
AF Takaoka, Kensuke
   Gourtsoyannis, Yannis
   Hart, John D.
   Armstrong, Margaret
   Daniel, Amanda
   Mewse, Emma
   Phillips, Diana
   Bailey, Robin L.
TI Incidence rate and risk factors for giardiasis and strongyloidiasis in
   returning UK travellers
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE giardiasis; strongyloidiasis; incidence; risk factor; travel medicine;
   multivariate analysis
ID STERCORALIS; EPIDEMIOLOGY; COUNTRY
AB Background: Few studies have investigated incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. The clinical presentations of these two diseases are often similar and difficult to distinguish. This study was conducted to investigate the incidence rate and the risk factors for symptomatic giardiasis and strongyloidiasis in returned tropical travellers.
   Methods: We retrospectively analysed 3306 consecutive attendances presenting to the emergency clinic at the Hospital for Tropical Diseases in London, the UK from September 2008 to May 2010. Odds ratios between the diagnoses and patient variables were analysed by logistic regression.
   Results: Giardiasis was diagnosed in 92/3306 cases (2.8%, proportionate morbidity), and the incidence rate per 1000 person-months was 12.5. Multivariate analysis with logistic regression revealed that Caucasian ethnicity (adjusted odds ratio (aOR): 2.37, 95% confidence interval (CI): 1.12-5.03, P value = 0.025), travel length a parts per thousand yen32 days (aOR: 2.63, 95%CI: 1.43-4.83, P = 0.002), travelling to South or South East Asia (aOR: 4.90, 95%CI: 2.03-11.8, P < 0.001, aOR: 3.36, 95%CI: 1.43-7.93, P = 0.006), afebrile presentation (aOR: 2.14, 95%CI: 1.14-4.03, P = 0.018), and presenting with gastro-intestinal symptoms (aOR: 14.6, 95%CI: 6.08-35.0, P < 0.001) were all associated with giardiasis. In contrast, strongyloidiasis was found only in 0.94% (proportionate morbidity) of the cases (31/3306), and the incidence rate per 1000 person-months was 3.1. Multivariate analysis revealed that male sex (aOR: 3.05, 95%CI: 1.36-6.85, P = 0.007), and non-Caucasian ethnicity (aOR: 2.69, 95%CI: 1.32-5.49, P = 0.007) were associated with strongyloidiasis.
   Conclusions: The incidence rate and risk factors for both infectious diseases were identified. The results of this study might guide clinicians to make more accurate and timely diagnoses in returned tropical travellers.
C1 [Takaoka, Kensuke; Gourtsoyannis, Yannis; Hart, John D.; Bailey, Robin L.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
   [Armstrong, Margaret; Daniel, Amanda; Mewse, Emma; Phillips, Diana; Bailey, Robin L.] Hosp Trop Dis, London, England.
RP Takaoka, K (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
EM roddy-kyu@umin.ac.jp
CR Association TT, 2013, ASS TT TRAVEL TRENDS
   Baaten GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-84
   Bisoffi Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002214
   Bukasa A, 2007, FOREIGN TRAVEL ASS I
   Buonfrate D, 2012, CURR INFECT DIS REP, V14, P256, DOI 10.1007/s11908-012-0248-6
   Curtale F, 1998, J TROP PEDIATRICS, V44, P323, DOI 10.1093/tropej/44.6.323
   Dakic Z, 2011, EUR J MICROBIOL IMMU, V1, P80, DOI 10.1556/EuJMI.1.2011.1.10
   Ekdahl K, 2005, AM J TROP MED HYG, V72, P825, DOI 10.4269/ajtmh.2005.72.825
   GILMAN RH, 1985, T ROY SOC TROP MED H, V79, P469, DOI 10.1016/0035-9203(85)90068-9
   Jelinek T, 2000, J TRAVEL MED, V7, P70
   Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004
   Pacanowski J, 2005, AM J TROP MED HYG, V73, P122, DOI 10.4269/ajtmh.2005.73.122
   Ramirez-Olivencia G, 2014, INT J INFECT DIS, V18, P32, DOI 10.1016/j.ijid.2013.09.009
   Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777
   Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288
   STONE OJ, 1972, ARCH DERMATOL, V106, P734, DOI 10.1001/archderm.106.5.734
   Sudarshi S, 2003, TROP MED INT HEALTH, V8, P728, DOI 10.1046/j.1365-3156.2003.01069.x
   Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008
   Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046
NR 19
TC 6
Z9 6
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD SEP
PY 2016
VL 23
IS 5
AR taw050
DI 10.1093/jtm/taw050
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA DV9MN
UT WOS:000383264700001
PM 27432907
OA Bronze
DA 2020-12-01
ER

PT J
AU Marks, M
   Armstrong, M
   Whitty, CJM
   Doherty, JF
AF Marks, Michael
   Armstrong, Margaret
   Whitty, Christopher J. M.
   Doherty, Justin F.
TI Geographical and temporal trends in imported infections from the tropics
   requiring inpatient care at the Hospital for Tropical Diseases, London -
   a 15 year study
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Enteric fever; Febrile illness; Imported infections; Malaria; Travellers
ID FALCIPARUM-MALARIA; SURVEILLANCE DATA; TRAVELERS; FEVER
AB Background: Understanding geographic and temporal trends in imported infections is key to the management of unwell travellers. Many tropical infections can be managed as outpatients, with admission reserved for severe cases.
   Methods: We prospectively recorded the diagnosis and travel history of patients admitted between 2000 and 2015. We describe the common tropical and non-tropical infectious diseases and how these varied based on region, reason for travel and over time.
   Results: A total of 4362 admissions followed an episode of travel. Falciparum malaria was the most common diagnosis (n=1089). Among individuals who travelled to Africa 1206/1724 (70.0%) had a tropical diagnosis. The risk of a tropical infection was higher among travellers visiting friends and relatives than holidaymakers (OR 2.8, p<0.001). Among travellers to Asia non-tropical infections were more common than tropical infections (349/782, 44.6%), but enteric fever (117, 33.5%) of the tropical infections and dengue (70, 20.1%) remained important. The number of patients admitted with falciparum malaria declined over the study but those of enteric fever and dengue did not.
   Conclusions: Most of those arriving from sub-Saharan Africa with an illness requiring admission have a classical tropical infection, and malaria still predominates. In contrast, fewer patients who travelled to Asia have a tropical diagnosis but enteric fever and dengue remain relatively common. Those visiting friends and relatives are most likely to have a tropical infection.
C1 [Marks, Michael; Armstrong, Margaret; Whitty, Christopher J. M.; Doherty, Justin F.] Hosp Trop Dis, London, England.
   [Marks, Michael; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.
RP Marks, M (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1E 7HT, England.
EM michael.marks@lshtm.ac.uk
OI Marks, Michael/0000-0002-7585-4743
FU Wellcome Trust Clinical Research FellowshipWellcome Trust [102807]; NIHR
   Biomedical Research CentresNational Institute for Health Research
   (NIHR); Special Trustees of the Hospital for Tropical Diseases; National
   Institute for Health ResearchNational Institute for Health Research
   (NIHR) [ACF-2012-20-001] Funding Source: researchfish
FX MM is supported by a Wellcome Trust Clinical Research Fellowship -
   102807. This work was undertaken at UCLH/UCL who received a proportion
   of funding from the NIHR Biomedical Research Centres funding scheme. MA
   was supported by the Special Trustees of the Hospital for Tropical
   Diseases.
CR Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Broderick C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001854
   Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116
   Checkley AM, 2010, J INFECTION, V60, P1, DOI 10.1016/j.jinf.2009.11.003
   Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195
   Date KA, 2016, CLIN INFECT DIS, V63, P322, DOI 10.1093/cid/ciw232
   Datu K, 2014, MIGRATION LONDONS GR
   Fitzpatrick C, 2016, INT HEALTH, V8, pi15, DOI 10.1093/inthealth/ihw002
   Johnston V, 2009, J INFECTION, V59, P1, DOI 10.1016/j.jinf.2009.05.005
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118
   Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x
   ONS, 2014, TRAV TRENDS 2013
   Pitzer VE, 2015, CLIN INFECT DIS, V61, pS251, DOI 10.1093/cid/civ710
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Siikamaki H, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.19.21128
   Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120
   Van Bortel W, 2014, EURO SURVEILL B EUR, V19
NR 18
TC 8
Z9 8
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD AUG
PY 2016
VL 110
IS 8
BP 456
EP 463
DI 10.1093/trstmh/trw053
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EA6SG
UT WOS:000386758600004
PM 27618924
OA Green Published, Green Accepted, Other Gold
DA 2020-12-01
ER

PT J
AU Nabarro, LEB
   Aggarwal, D
   Armstrong, M
   Lockwood, DNJ
AF Nabarro, Laura E. B.
   Aggarwal, Dinesh
   Armstrong, Margaret
   Lockwood, Diana N. J.
TI The use of steroids and thalidomide in the management of Erythema
   Nodosumn Leprosum; 17 years at the Hospital for Tropical Diseases,
   London
SO LEPROSY REVIEW
LA English
DT Article
ID AZATHIOPRINE; DEXAMETHASONE; EXPERIENCE; ETHIOPIA; COHORT; INDIA
AB Objectives: Prednisolone and thalidomide are commonly used in the management of erythema nodosum leprosum (ENL) and bring relief to patients with this condition worldwide. However, both ENL and its treatments can cause significant morbidity. This study describes the spectrum of ENL seen at The Hospital for Tropical Diseases, London (HTD), the use of steroids and thalidomide in its management and the complications of their use.
   Study Design: We conducted a retrospective audit of patients diagnosed with ENL between 1996 and 2013. Data were obtained from hospital records including severity and length of disease, together with treatments received and adverse effects.
   Results: Between 1996 and 2013, 30 patients were diagnosed with ENL. The median bacillary index (BI) at diagnosis was 465, higher than in previous studies. Most patients developed ENL during leprosy treatment (67%) and had chronic ENL (57%). The median length of ENL was 60 months (range 9-192); patients with BI > 4.5 had significantly longer duration of disease. 87% patients received prednisolone for median nine months; 35% developed adverse effects including diabetes and hypertension. 87% patients received thalidomide for median 16 months; 65% complained of side effects. There were no pregnancies or venous thromboembolisms. 77% patients stopped prednisolone within two months of starting thalidomide. There were no deaths in our cohort.
   Conclusion: We describe the clinical course of ENL in a non-endemic country with access to thalidomide and prednisolone. ENL may last far longer than previously described and has significant impact on a patient's health. In the UK, thalidomide is essential as a steroid-sparing agent, to prevent the adverse effects and mortality of long-term steroids which have been documented elsewhere.
C1 [Nabarro, Laura E. B.; Aggarwal, Dinesh; Armstrong, Margaret; Lockwood, Diana N. J.] Hosp Trop Dis, Capper St, London WC1E 6JB, England.
   [Lockwood, Diana N. J.] London Sch Hyg & Trop Med, London, England.
RP Nabarro, LEB (corresponding author), Hosp Trop Dis, Capper St, London WC1E 6JB, England.
EM Laura.nabarro@nhs.net
FU Special Trustees of the Hospital for Tropical Diseases; University
   College London Hospitals Comprehensive Biomedical Research Centre
   Infection Theme
FX M. Armstrong is supported by the Special Trustees of the Hospital for
   Tropical Diseases. All authors were supported by the University College
   London Hospitals Comprehensive Biomedical Research Centre Infection
   Theme. The supporting agencies had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Duraes SMB, 2011, LEPROSY REV, V82, P304
   Bell M, 2008, EMPIRICAL ANAL EFFEC
   Chandler DJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003431
   Faber WR, 2006, NEW ENGL J MED, V355, P739, DOI 10.1056/NEJMc052955
   Feuth M, 2008, LEPROSY REV, V79, P254
   Kahawita IP, 2008, T ROY SOC TROP MED H, V102, P329, DOI 10.1016/j.trstmh.2008.01.004
   Kumar B, 2004, INT J LEPROSY, V72, P125, DOI 10.1489/1544-581X(2004)072&lt;0125:ECOLRY&gt;2.0.CO;2
   Mahajan VK, 2003, LEPROSY REV, V74, P171
   Nery Jose A. C., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P363, DOI 10.1590/S0036-46651998000600005
   Papang R, 2009, Indian J Lepr, V81, P125
   Pocaterra L, 2006, AM J TROP MED HYG, V74, P868, DOI 10.4269/ajtmh.2006.74.868
   Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221
   Ramien ML, 2011, CLIN INFECT DIS, V52, pE133, DOI 10.1093/cid/ciq213
   Saunderson P, 2000, LEPROSY REV, V71, P318
   Sugumaran DST, 1998, INT J LEPROSY, V66, P10
   Uhl K, 2006, DRUG SAFETY, V29, P321, DOI 10.2165/00002018-200629040-00003
   Van Veen NHJ, 2009, LEPROSY REV, V80, P355
   Verma KK, 2006, LEPROSY REV, V77, P225
   Voorend CGN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002440
   Walker SL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002690
   Walker SL, 2007, LEPROSY REV, V78, P197
NR 21
TC 6
Z9 7
U1 0
U2 5
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD JUN
PY 2016
VL 87
IS 2
BP 221
EP 231
PG 11
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA DT5SN
UT WOS:000381543000009
DA 2020-12-01
ER

PT J
AU Armstrong, M
   D'Arrigo, R
   Petter, C
   Galli, A
AF Armstrong, Margaret
   D'Arrigo, Rafael
   Petter, Carlos
   Galli, Alain
TI How resource-poor countries in Asia are securing stable long-term
   reserves: Comparing Japan's and South Korea's approaches
SO RESOURCES POLICY
LA English
DT Article
DE Copper; LNG; JBIC; KNOC; KORES; Wasting taxpayers' money
AB Securing stable long-term supplies of raw materials is vital for industrialized nations. China, Japan and South Korea are three countries in East Asia which import large quantities of raw material, especially metals and petroleum products. Unlike the other two, China has large mines and oilfields and so can use this expertise to exploit resources overseas. In contrast Japan and South Korea are resource-poor countries that lack domestic petroleum and mining industries.
   This paper compares the ways in which these two countries secure supplies. Japanese trading companies and industrial groups invest in mining and petroleum projects run by international groups with the active support from the Japanese government through the Japan Bank for International Cooperation (JBIC). In contrast, the Korean government has set up two state run corporations: the Korea Resource Corporation, KORES, for minerals, and the Korean National Oil Corporation KNOC for oil and LNG, which usually take a leading role in choosing projects, though they do work in partnership with large Korean private sector groups. After his election in 2008, President Lee Myung-bak put pressure on public sector entities to speed up investments in mining and petroleum projects, which resulted in unsuitable projects being financed and public money being wasted. We argue that three lessons can be learned from this: firstly, building up a solid basis of natural resources takes decades and should not be rushed; secondly, project finance in the sense of non-recourse funding provides better checks and balances than direct acquisitions do and thirdly more transparency is required when spending taxpayers' money. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Armstrong, Margaret; D'Arrigo, Rafael; Galli, Alain] PSL Res Univ, MINES Paristech, CERNA, i3,CNRS,UMR 9217, Paris, France.
   [Armstrong, Margaret] Fundacao Getulio Vargas, EMAp, 190 Praia Botafogo, Rio De Janeiro, Brazil.
   [D'Arrigo, Rafael; Petter, Carlos] Univ Fed Rio Grande do Sul, Min Dept, Porto Alegre, RS, Brazil.
RP Armstrong, M (corresponding author), Fundacao Getulio Vargas, EMAp, 190 Praia Botafogo, Rio De Janeiro, Brazil.
EM margaret.armstrong@mines-paristech.fr; rafael@engdeminas.com.br;
   cpetter@ufrgs.br; alain.galli@mines-paristech.fr
RI Petter, Carlos/AAE-9945-2019
OI Freitas D Arrigo, Rafael/0000-0002-4239-4330
FU Brazilian CNPq program, Science without Frontiers [249971/2013-5]
FX Rafael Freitas D'Arrigo gratefully acknowledges support from the
   Brazilian CNPq program, Science without Frontiers, Grant 249971/2013-5,
   which provided his scholarship to spend a sandwich year at the Ecole des
   Mines during his Ph.D. thesis.
CR Albanese T., 2008, MEDIA COMMUNITY SITE
   [Anonymous], 2015, JOGMECS ACT
   [Anonymous], 2013, JBIC PROF ROL FUNCT
   [Anonymous], 2014, BBC NEWS
   [Anonymous], 2014, JBIC ANN REP, P3
   Chazan G., 2013, PETROCHINA BUYS IRAQ
   Donati J, 2013, LANDMARK CHINESE COP
   Ernstberger J., 2015, REAL EFFECTS MANDATO
   Ex-Im, 2014, CLOSING DOCUMENTS EX, P36
   Fay P., 2015, COUR COMPTES TANCE V
   Forbes, 2013, FORBES
   Gigler F, 2014, J ACCOUNT RES, V52, P357, DOI 10.1111/1475-679X.12043
   Gordyeva M., 2013, CHINA BUYS GIANT KAZ
   Hatayama H, 2015, RESOUR POLICY, V44, P72, DOI 10.1016/j.resourpol.2015.02.004
   Hyo-Jin Kim, 2015, LAWMAKERS BEGIN ONSI
   Japan Mining Industry Association, 2013, MONTHL STAT TOK JAP
   JBIC, 2014, EX BUS OUTC FY2013
   JBIC, 2012, EN NAT RES FIN SIERR
   JBIC, 2012, LOAN ESC COPP MIN EX
   JBIC, 2012, PROJ FIN IN JAP BUS
   JBIC, 2013, PROJ FIN ANT COPP MI
   JBIC, 2012, LOAN CAS COPP MIN PR
   Ji-Yoon Kim, 2014, ENERGY RESOURCES DRI
   Jojin J., 2013, WEDN SEM I CHIN STUD
   Kantei, 2013, JAP REV STRAT JAP BA
   Koh Jung-Sik, 2015, WORDS OUR CEO
   Kuo Chin S., 2014, USGS MINERALS YEAR B
   Lee C., 2014, S KOREAS STATE KNOC
   Lesbirel SH, 2004, JPN J POLIT SCI, V5, P1, DOI DOI 10.1017/S146810990400129X
   McCrae MA, 2013, WORST MINING DEAL EV
   Mundy S., 2015, FT FIRST        0421
   Nam In-Soo, 2013, WALL STREET J ASIA
   OECD, 1976, SUMM ARR EXP CRED
   Okeowo Alexis, 2013, NEW YORKER
   Oliver C., 2011, S KOR DIPL FIR
   Rahn Kim, 2015, PROSECUTION RAIDS KO
   Shi Lin, 2014, USGS MINERALS YB N K
   Suk-Yee Jung, 2015, SUNG WAN JONG CONFES
   TU HS, 2002, BUS HORIZONS, V45, P39
   Vivoda V, 2012, ENERG POLICY, V46, P135, DOI 10.1016/j.enpol.2012.03.044
   Vivoda V, 2011, J EAST ASIAN STUD, V11, P223, DOI 10.1017/S1598240800007177
   Wigglesworth R., 2010, FT              0623
   Yee A., 2012, S KOREA OIL DEAL MAK
NR 43
TC 2
Z9 2
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4207
EI 1873-7641
J9 RESOUR POLICY
JI Resour. Policy
PD MAR
PY 2016
VL 47
BP 51
EP 60
DI 10.1016/j.resourpol.2015.12.001
PG 10
WC Environmental Studies
SC Environmental Sciences & Ecology
GA DG2ZB
UT WOS:000371938200006
DA 2020-12-01
ER

PT J
AU Marks, ME
   Armstrong, M
   Whitty, C
   Doherty, JF
AF Marks, Michael E.
   Armstrong, Margaret
   Whitty, Christopher
   Doherty, Justin F.
TI TRENDS IN IMPORTED INFECTIONS IN THE UNITED KINGDOM: 2000-2015
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Marks, Michael E.; Whitty, Christopher] London Sch Hyg & Trop Med, London, England.
   [Armstrong, Margaret; Doherty, Justin F.] Hosp Trop Dis, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 647
BP 195
EP 195
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844102389
DA 2020-12-01
ER

PT J
AU Henry, B
   Morizot, G
   Blum, J
   Van der Auwera, G
   Clerinx, J
   Harms, G
   Bart, A
   Armstrong, M
   Ravel, C
   Robert-Gangneux, F
   Gangneux, JP
   Felger, I
   Bailey, M
   Grogl, M
   Lockwood, D
   Buffet, P
AF Henry, B.
   Morizot, G.
   Blum, J.
   Van der Auwera, G.
   Clerinx, J.
   Harms, G.
   Bart, A.
   Armstrong, M.
   Ravel, C.
   Robert-Gangneux, F.
   Gangneux, J. -P.
   Felger, I.
   Bailey, M.
   Groegl, M.
   Lockwood, D.
   Buffet, P.
CA LeishMan Network
TI Worldwide diversity of leishmaniasis: harmonized collection of data and
   isolates by the European "LeishMan" network: the LeishMan Network
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Henry, B.] Univ Paris 05, Hop Necker Enfants Malad, APHP, Serv Malad Infect & Trop,Sorbonne Paris Cite,Ctr, B-2000 Paris, France.
   [Morizot, G.] Inst Pasteur, Invest Clin & Acces Ressources Biol, D-13353 Paris, France.
   [Blum, J.; Felger, I.] Swiss Trop & Publ Hlth Inst, NL-1105 AZ Basel, Switzerland.
   [Van der Auwera, G.; Clerinx, J.] Inst Trop Med, Antwerp NW1 0PE, Belgium.
   [Harms, G.] Charite, Inst Tropenmed & Int Gesundheit, Berlin, Germany.
   [Bart, A.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands.
   [Armstrong, M.; Lockwood, D.] Hosp Trop Dis, London, England.
   [Ravel, C.] CHU Montpellier, Fac Med Montpellier, Montpellier, France.
   [Robert-Gangneux, F.; Gangneux, J. -P.] Univ Rennes 1, CHU Rennes, Rennes, France.
   [Bailey, M.] Royal Ctr Def Med, Birmingham, W Midlands, England.
   [Groegl, M.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Buffet, P.] Univ Paris 06, Sorbonne Univ, Hop La Pitie Salpetriere, Serv Parasitol & Mycol, Paris, France.
RI Buffet, Pierre A/O-6189-2017; Bart, Aldert/B-9520-2008; Ravel,
   Christophe/A-7369-2008; ROBERT-GANGNEUX, Florence/I-4692-2015
OI Buffet, Pierre A/0000-0003-4010-929X; Bart, Aldert/0000-0001-6605-6347; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2015
VL 20
SU 1
SI SI
BP 35
EP 35
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CQ7BW
UT WOS:000360758800084
DA 2020-12-01
ER

PT J
AU Saito, M
   Armstrong, M
   Boadi, S
   Lowe, P
   Chiodini, PL
   Doherty, T
AF Saito, Makoto
   Armstrong, Margaret
   Boadi, Samuel
   Lowe, Patricia
   Chiodini, Peter L.
   Doherty, Tom
TI Clinical Features of Imported Loiasis: A Case Series from the Hospital
   for Tropical Diseases, London
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID LOA-LOA FILARIASIS; AFRICAN EYE WORM; HYPERRESPONSIVE SYNDROME; ENDEMIC
   REGIONS; IVERMECTIN; DIETHYLCARBAMAZINE; ONCHOCERCIASIS; INFECTION
AB We retrospectively analyzed the background, clinical features, and treatment response of 50 cases of imported loiasis who presented between 2000 and 2014 to the Hospital for Tropical Diseases (HTD), London, United Kingdom. Of them, 29 were migrants from, and 21 were visitors to, countries where the disease is endemic. Clinical features differed between these groups. Migrants experienced fewer Calabar swellings (odds ratio [OR] = 0.12), more eye worm (OR = 3.4), more microfilaremia (OR = 3.5), lower filarial antibody levels, and lower eosinophil counts (P < 0.05 for all tests). Among 46 patients who were started on treatment at WED, 33 (72%) received diethylcarbamazine (DEC) monotherapy as first-line treatment, and among 26 patients who were followed up after treatment, seven (27%) needed a second course of treatment. There were 46 courses of treatment with DEC, and 20 (43%) of them had reactions. All patients with microfilaremia > 3,000 microfilariae/mL and all those with an elevated C-reactive protein (CRP) (>= 5 mg/L) before treatment had reactions (P = 0.10 and P = 0.01, respectively). These data suggest that monotherapy with DEC may not be the optimal treatment for patients with loiasis, particularly for those with a high microfilarial load.
C1 Hosp Trop Dis, London NW1 0PE, England.
   [Saito, Makoto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Saito, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM makosaitou-tky@umin.ac.jp
RI Saito, Makoto/O-7383-2019
OI Saito, Makoto/0000-0002-1667-9287
FU GlaxoSmithKline International Scholarship Charitable Trust Fund;
   National Institute for Health Research University College London
   Hospitals Biomedical Research Centre
FX Makoto Saito is supported by GlaxoSmithKline International Scholarship
   Charitable Trust Fund. Margaret Armstrong is supported by the Special
   Trustees of the Hospital for Tropical Diseases. Peter L. Chiodini is
   supported by the National Institute for Health Research University
   College London Hospitals Biomedical Research Centre.
CR Ali S, 2008, J TRAVEL MED, V15, P50, DOI 10.1111/j.1708-8305.2007.00166.x
   Antinori S, 2012, INT J INFECT DIS, V16, pE649, DOI 10.1016/j.ijid.2012.05.1023
   Boussinesq M, 1998, AM J TROP MED HYG, V58, P461, DOI 10.4269/ajtmh.1998.58.461
   Boussinesq M, 2006, ANN TROP MED PARASIT, V100, P715, DOI 10.1179/136485906X112194
   Boussinesq Michel, 2003, Filaria J, V2 Suppl 1, pS4, DOI 10.1186/1475-2883-2-S1-S4
   Boussinesq M, 2012, J TRAVEL MED, V19, P140, DOI 10.1111/j.1708-8305.2012.00605.x
   CARME B, 1991, AM J TROP MED HYG, V44, P684, DOI 10.4269/ajtmh.1991.44.684
   Churchill DR, 1996, J INFECTION, V33, P103, DOI 10.1016/S0163-4453(96)93005-4
   Gantois N, 2013, TRAVEL MED INFECT DI, V11, P366, DOI 10.1016/j.tmaid.2013.08.005
   Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1
   Ghys C, 2012, J TRAVEL MED, V19, P186, DOI 10.1111/j.1708-8305.2012.00604.x
   Gobbi F, 2014, TRAVEL MED INFECT DI, V12, P713, DOI 10.1016/j.tmaid.2014.07.004
   Kamgno J, 2007, T ROY SOC TROP MED H, V101, P777, DOI 10.1016/j.trstmh.2007.03.018
   KLION AD, 1994, J INFECT DIS, V169, P604, DOI 10.1093/infdis/169.3.604
   KLION AD, 1991, J INFECT DIS, V163, P1318, DOI 10.1093/infdis/163.6.1318
   Lipner EM, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000088
   Metzger WG, 2014, LANCET INFECT DIS, V14, P353, DOI 10.1016/S1473-3099(13)70263-9
   NUTMAN TB, 1986, J INFECT DIS, V154, P10, DOI 10.1093/infdis/154.1.10
   NUTMAN TB, 1988, J INFECT DIS, V157, P544, DOI 10.1093/infdis/157.3.544
   Padgett JJ, 2008, T ROY SOC TROP MED H, V102, P983, DOI 10.1016/j.trstmh.2008.03.022
   Takougang I, 2007, ANN TROP MED PARASIT, V101, P151, DOI 10.1179/136485907X154511
   Twum-Danso Nana AY, 2003, Filaria J, V2 Suppl 1, pS7, DOI 10.1186/1475-2883-2-S1-S7
   Wahl G, 1995, TROP MED PARASITOL, V46, P287
   Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210
NR 24
TC 12
Z9 14
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD SEP
PY 2015
VL 93
IS 3
BP 607
EP 611
DI 10.4269/ajtmh.15-0214
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CR3TB
UT WOS:000361254900033
PM 26101271
OA Green Published, Bronze, Green Accepted
DA 2020-12-01
ER

PT J
AU Coltart, CEM
   Chew, A
   Storrar, N
   Armstrong, M
   Suff, N
   Morris, L
   Chiodini, PL
   Whitty, CJM
AF Coltart, Cordelia E. M.
   Chew, Anastasia
   Storrar, Neill
   Armstrong, Margaret
   Suff, Natalie
   Morris, Leila
   Chiodini, Peter L.
   Whitty, Christopher J. M.
TI Schistosomiasis presenting in travellers: a 15 year observational study
   at the Hospital for Tropical Diseases, London
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Diagnosis; Schistosoma haematobium; Schistosoma mansoni;
   Schistosomiasis; Screening; Travellers
ID LABORATORY TESTS; EOSINOPHILIA; MANSONI; ELISA
AB Background: Schistosomiasis in returning travellers is one of the most common imported tropical infections with potentially serious complications, which are preventable if diagnosed early.
   Methods: A review was undertaken of consecutive cases of schistosomiasis presenting at the Hospital for Tropical Diseases, London, UK from 1997 to 2012.
   Results: All 1020 schistosomiasis cases were from Africa and Schistosoma haematobium was the predominant species in those with microscopy confirmed schistosomiasis (74.2%, 204/252). The number of cases of imported schistosomiasis is decreasing steadily as a proportion of travellers seen. The majority of cases were in travellers originating from non-endemic settings (81.8%, 707/864). The most common symptom was of genitourinary complaints (22.6%, 230/1020), predominantly haematuria (17.8%, 181/1020); 36.1% (368) of cases were asymptomatic. Overall 42% had eosinophilia, and 62% of ova positive S. haematobium cases had haematuria on urine dip. Thus, no single screening tool was sufficient to identify or rule out schistosomiasis when used alone. Serology testing was a more sensitive tool in travellers than in other patients (p=0.007).
   Conclusions: The prevalence of schistosomiasis in presenting travellers is decreasing. The predominant presenting species has shifted from S. mansoni to S. haematobium. No single test can reliably diagnose schistosomiasis, with eosinophilia and urine dip having low sensitivity. Clinicians need to continue to undertake a wide spectrum of diagnostic tests to ensure cases of schistosomiasis are not missed.
C1 [Coltart, Cordelia E. M.; Chew, Anastasia; Storrar, Neill; Armstrong, Margaret; Suff, Natalie; Chiodini, Peter L.; Whitty, Christopher J. M.] UCLH, Hosp Trop Dis, London WC1E 6JB, England.
   [Coltart, Cordelia E. M.; Chiodini, Peter L.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Morris, Leila] UCL, Sch Med, London WC1E 6BT, England.
RP Coltart, CEM (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, Keppel St, London WC1E 7HT, England.
EM cordelia.coltart@ucl.ac.uk
OI Whitty, Christopher/0000-0002-6076-5027; Storrar,
   Neill/0000-0002-4548-6468
FU National Institute for Health Research University College London
   Hospitals Biomedical Research Centre; Special Trustees of the Hospital
   for Tropical Diseases; University College London Hospitals Comprehensive
   Biomedical Research Centre Infection Theme
FX PLC is supported by the National Institute for Health Research
   University College London Hospitals Biomedical Research Centre. MA is
   supported by the Special Trustees of the Hospital for Tropical Diseases
   All authors are supported by the University College London Hospitals
   Comprehensive Biomedical Research Centre Infection Theme. The supporting
   agencies had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amorosa V, 2005, EMERG INFECT DIS, V11, P339, DOI 10.3201/eid1102.040600
   [Anonymous], 2012, WHO FACTSH SCHIST
   Bierman WFW, 2005, J TRAVEL MED, V12, P9, DOI 10.2310/7060.2005.00003
   Centers for Disease Control (CDC), 1984, MMWR Morb Mortal Wkly Rep, V33, P445
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004
   Grobusch MP, 2003, EUROP J TRAVEL MED, V10, P154
   Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3
   HARRIES AD, 1986, LANCET, V1, P86
   Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075
   KING CH, 2001, SCHISTOSOMIASIS, P115
   Meltzer E, 2006, EMERG INFECT DIS, V12, P1696, DOI 10.3201/eid1211.060340
   Mwakitalu ME, 2014, ACTA TROP, V133, P35, DOI 10.1016/j.actatropica.2014.01.012
   Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729
   ONS, 2012, TRAV TRENDS 2011
   Sesay S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-14
   Sudarshi S, 2003, TROP MED INT HEALTH, V8, P728, DOI 10.1046/j.1365-3156.2003.01069.x
   TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2
   Turner P, 2004, J CLIN PATHOL, V57, P1193, DOI 10.1136/jcp.2003.014779
   Van Bocxlaer Bert, 2014, Trends Parasitol, V30, P217, DOI 10.1016/j.pt.2014.02.006
   Whetham J, 2003, J INFECTION, V46, P180, DOI 10.1053/jinf.2002.1108
   Whitty CJM, 2000, TROP MED INT HEALTH, V5, P818, DOI 10.1046/j.1365-3156.2000.00642.x
   Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4
NR 23
TC 25
Z9 25
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2015
VL 109
IS 3
BP 214
EP 220
DI 10.1093/trstmh/tru195
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CD3LX
UT WOS:000350981100010
PM 25575554
DA 2020-12-01
ER

PT S
AU Armstrong, M
   Costa, L
   Galli, A
AF Armstrong, Margaret
   Costa, Leticia
   Galli, Alain
GP IEEE
TI The Evolution of Bidding Strategies in Spain following the Introduction
   of Renewable Energy
SO 2015 12TH INTERNATIONAL CONFERENCE ON THE EUROPEAN ENERGY MARKET (EEM)
SE International Conference on the European Energy Market
LA English
DT Proceedings Paper
CT 12th International Conference on the European Energy Market (EEM)
CY MAY 19-22, 2015
CL Lisbon, PORTUGAL
SP Inst Super Engn Lisboa, Power & Energy Soc, IEEE, Edp
DE Day-ahead market; Intraday market; Renewable energy; Strategic bidding
AB This study of the bidding strategies used by electricity producers in the day-ahead and intraday markets in Spain-Portugal shows that they clearly do respect the merit order. They offer their production at a range of prices which vary from one hour of the day to another, and from one day of the week to another. We show that on average over a quarter producers received about the same revenue per MWh sold irrespective of fuel type. The average dropped from 70-75 euro per MWh in 2008 to as low as 25 euro in 2010 because of the global crisis then rose to about 50 euro in 2012 despite the increasing quantity of renewal energy and the stagnation of the demand.
C1 [Armstrong, Margaret; Costa, Leticia; Galli, Alain] Mines Paristech, Cerna, Paris, France.
RP Armstrong, M (corresponding author), Mines Paristech, Cerna, Paris, France.
EM margaret.armstrong@mines-paristech.fr; leticiaalmeidacosta@gmail.com;
   alain.galli@mines-paristech.fr
CR [Anonymous], 2013, ECONOMIST
   David AK, 2000, 2000 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-4, P2168, DOI 10.1109/PESS.2000.866982
   FRANCO PEC, 1994, IEEE T POWER SYST, V9, P1016, DOI 10.1109/59.317642
   Khmel D, 2015, INT CONF EUR ENERG
   REE, 2012, SPAN EL SYST PREL RE
   Stoft S., 2002, POWER SYSTEM EC DESI
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2165-4077
BN 978-1-4673-6692-2
J9 INT CONF EUR ENERG
PY 2015
PG 5
WC Energy & Fuels; Engineering, Electrical & Electronic
SC Energy & Fuels; Engineering
GA BF1DJ
UT WOS:000380377200042
DA 2020-12-01
ER

PT S
AU Khmel, D
   Armstrong, M
   Galli, A
   Riviere, P
AF Khmel, Daria
   Armstrong, Margaret
   Galli, Alain
   Riviere, Philippe
GP IEEE
TI The idiosyncratic bidding strategies of electricity producers in Sicily
   and its impact on evaluating GHG emissions
SO 2015 12TH INTERNATIONAL CONFERENCE ON THE EUROPEAN ENERGY MARKET (EEM)
SE International Conference on the European Energy Market
LA English
DT Proceedings Paper
CT 12th International Conference on the European Energy Market (EEM)
CY MAY 19-22, 2015
CL Lisbon, PORTUGAL
SP Inst Super Engn Lisboa, Power & Energy Soc, IEEE, Edp
DE Day-ahead market; Demand Side Management; GME; Renewable energy;
   Strategic bidding
AB Often studies on the impact of demand side management on GHG emissions assume that power plants respect the merit order when bidding on electricity markets. By analyzing bidding patterns in Sicily from 2006 to 2012 we show that this is not the case. Generators offer their production at prices ranging from zero upwards. Going further we estimate the GHG emissions of the power plants that were actually dispatched compared to those that would have been dispatched if producers respected the merit order rule. This highlights the need for in-depth studies of actual bidding strategies.
C1 [Khmel, Daria; Armstrong, Margaret; Galli, Alain] PSL Res Univ, Mines Paristech, Cerna, 60 Blvd St Michel, F-75272 Paris, France.
   [Riviere, Philippe] PSL Res Univ, Mines Paristech, CES, F-75272 Paris, France.
RP Khmel, D (corresponding author), PSL Res Univ, Mines Paristech, Cerna, 60 Blvd St Michel, F-75272 Paris, France.
EM daria.khmel@gmail.com; margaret.armstrong@mines-paristech.fr;
   alain.galli@mines-paristech.fr; philippe.riviere@mines-paristech.fr
CR Armstrong M, 2015, EEM15 C LISB 20 22 M
   Colbalchini R., 2014, THESIS
   David AK, 2000, 2000 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-4, P2168, DOI 10.1109/PESS.2000.866982
   FRANCO PEC, 1994, IEEE T POWER SYST, V9, P1016, DOI 10.1109/59.317642
   Hawkes AD, 2010, ENERG POLICY, V38, P5977, DOI 10.1016/j.enpol.2010.05.053
   Petti A., 2007, GME ROM TUR SEPT 200
   Stoft S., 2002, POWER SYSTEM EC DESI
   Strbac G, 2008, ENERG POLICY, V36, P4419, DOI 10.1016/j.enpol.2008.09.030
NR 8
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2165-4077
BN 978-1-4673-6692-2
J9 INT CONF EUR ENERG
PY 2015
PG 5
WC Energy & Fuels; Engineering, Electrical & Electronic
SC Energy & Fuels; Engineering
GA BF1DJ
UT WOS:000380377200109
DA 2020-12-01
ER

PT J
AU Calili, RF
   Souza, RC
   Galli, A
   Armstrong, M
   Marcato, ALM
AF Calili, Rodrigo F.
   Souza, Reinaldo C.
   Galli, Alain
   Armstrong, Margaret
   Marcato, Andre Luis M.
TI Estimating the cost savings and avoided CO2 emissions in Brazil by
   implementing energy efficient policies
SO ENERGY POLICY
LA English
DT Article
DE Geometric Brownian motion; Hydrothermal power system; Stochastic dual
   dynamic programming
ID STOCHASTIC OPTIMIZATION; SYSTEM
AB Investing more in renewable energy sources and using this in a rational and efficient way is vital for the sustainable growth of world. Energy efficiency (EE) will play an increasingly important role in future generations. The aim of this work is to estimate how much the PNEf (National Plan for Energy Efficiency) launched by the Brazilian government in 2011 will save over the next 5 years by avoiding the construction of additional power plants, as well as the amount of the CO2 emission.
   The marginal operating cost is computed for medium term planning of the dispatching of power plants in the hydro-thermal system using Stochastic Dynamic Dual Programming, after incorporating stochastic energy efficiencies into the demand for electricity. We demonstrate that even for a modest improvement in energy efficiency (< 1% per year), the savings over the next 5 years range from R$ 237 million in the conservative scenario to R$ 268 million(1) in the optimistic scenario. By comparison the new Belo Monte hydro-electric plant will cost R$ 26 billion to be repaid over a 30 year period (i.e. R$ 867 million in 5 years). So in Brazil EE policies are preferable to building a new power plant. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Calili, Rodrigo F.; Souza, Reinaldo C.] Pontificia Univ Catolica Rio de Janeiro PUC Rio, Dept Elect Engn, BR-22451900 Rio De Janeiro, RJ, Brazil.
   [Galli, Alain; Armstrong, Margaret] Mines Paristech, F-75006 Paris, France.
   [Marcato, Andre Luis M.] Univ Fed Juiz de Fora, BR-36036900 Juiz de Fora, MG, Brazil.
RP Calili, RF (corresponding author), Pontificia Univ Catolica Rio de Janeiro PUC Rio, Dept Elect Engn, Marques de Sao Vicente St,225 Gavea, BR-22451900 Rio De Janeiro, RJ, Brazil.
EM rcalili@ele.puc-rio.br
RI Marcato, Andre LM/E-6809-2018
OI Marcato, Andre LM/0000-0001-9171-3089; Calili,
   Rodrigo/0000-0002-3528-0773
CR Andrade & Canellas, 2012, WEBS CONT INF BEL MO
   Bayod-Rujula AA, 2009, ENERGY, V34, P377, DOI 10.1016/j.energy.2008.12.008
   Bertoldi P, 2008, ENERG EFFIC, V1, P237, DOI 10.1007/s12053-008-9021-y
   Brandi R.B.S., 2011, THESIS U FEDERAL JUI
   CEPEL (Centro de Pesquisa de Energia Eletrica), 2013, WEBS PROV PROGR SOLD
   Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1
   Marreco JD, 2006, ENERG POLICY, V34, P3749, DOI 10.1016/j.enpol.2005.08.020
   Dias BH, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/390940
   Dixit A.K., 1993, INVESTMENT UNCERTAIN
   Einstein A., 1956, INVESTIGATIONS THEOR
   Geller H, 2004, ENERG POLICY, V32, P1437, DOI 10.1016/S0301-4215(03)00122-8
   GORENSTIN BG, 1992, IEEE T POWER SYST, V7, P791, DOI 10.1109/59.141787
   HULL J, 1990, REV FINANC STUD, V3, P573, DOI 10.1093/rfs/3.4.573
   IEA-International Energy Agency. 2001, 2001, 8 DEM SID BIDD TOD E
   Langniss O, 2006, ENERG POLICY, V34, P200, DOI 10.1016/j.enpol.2004.08.025
   MCTI Ministry of Science, 2012, CO2 EM FACT
   Meade N, 2010, ENERG ECON, V32, P1485, DOI 10.1016/j.eneco.2010.07.010
   Merton R.C., 1976, J FINANC ECON, V2
   Oikonomou V, 2007, ENERG POLICY, V35, P1147, DOI 10.1016/j.enpol.2006.02.017
   ONS, 2013, PLAN OP EN 2013 2017
   Pereira M.V.F., 1983, IEEE T POWER SYST
   Pereira M.V.F., 1982, IEEE T POWER SYST
   PEREIRA MVF, 1989, INT J ELEC POWER, V11, P161, DOI 10.1016/0142-0615(89)90025-2
   PEREIRA MVF, 1985, WATER RESOUR RES, V21, P779, DOI 10.1029/WR021i006p00779
   Pina A, 2012, ENERGY, V41, P128, DOI 10.1016/j.energy.2011.06.013
   Garcia AGP, 2007, ENERG POLICY, V35, P3424, DOI 10.1016/j.enpol.2006.11.024
   Pinto L.M.V.G., 1990, MATH PROGRAM
   Souza RC, 2012, EUR J OPER RES, V222, P606, DOI 10.1016/j.ejor.2012.05.020
   Strbac G, 2008, ENERG POLICY, V36, P4419, DOI 10.1016/j.enpol.2008.09.030
   Terry LA, 1980, TECHNICAL REPORT
   UNFCCC, 2009, 50 UNFCCC EB, P31
   UNFCCC, 2006, ACM0002 CONS BAS MET
NR 32
TC 12
Z9 12
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4215
EI 1873-6777
J9 ENERG POLICY
JI Energy Policy
PD APR
PY 2014
VL 67
BP 4
EP 15
DI 10.1016/j.enpol.2013.09.071
PG 12
WC Economics; Energy & Fuels; Environmental Sciences; Environmental Studies
SC Business & Economics; Energy & Fuels; Environmental Sciences & Ecology
GA AC8WH
UT WOS:000332815300002
DA 2020-12-01
ER

PT J
AU Marks, M
   Armstrong, M
   Walker, D
   Doherty, T
AF Marks, Michael
   Armstrong, Margaret
   Walker, David
   Doherty, Tom
TI Imported falciparum malaria among adults requiring intensive care:
   analysis of the literature
SO MALARIA JOURNAL
LA English
DT Article
DE Malaria; Imported infections; ICU; ARDS
ID UNIT; BASEL
AB Background: Malaria is the most important imported tropical disease. Infection with Plasmodium falciparum is responsible for most of the morbidity and mortality. There are differences in both the epidemiology of imported malaria and in the facilities available to treat travellers with severe malaria between different parts of the world. There are limited data to guide clinicians caring for adults with imported malaria in an intensive care unit (ICU). Available data from the English-speaking literature concerning such patients was reviewed.
   Methods: PubMed was searched for studies on adults with imported malaria treated in an ICU. Data were extracted on the epidemiology, management, rates of concomitant community-acquired bacterial infection and outcomes.
   Results: Thirteen studies were identified, which between them included 1,001 patients over more than 40 years. Forty-one per cent were born and often still resident in an endemic country and were assumed to have at least partial immunity to the disease. Acute kidney injury (AKI) (36%), acute respiratory distress syndrome (ARDS) (31%) and impaired consciousness (25%) were common. Hyperparasitaemia (more than 2%) was seen in 57%. Thirty-four per cent required mechanical ventilation and 22% required renal replacement therapy. Community-acquired bacterial co-infection was seen in 8%; 2% had gram-negative bacteraemia at admission. Overall the case fatality rate was 9%.
   Conclusions: Many patients who require admission to ICU were originally from malaria-endemic countries and many did not have hyperparasitaemia. Gram-negative bacteraemia was uncommon among adults with severe malaria. The case fatality rate remains high; however, improvements in ICU care and increasing use of artemisinins may reduce this in the future.
C1 [Marks, Michael; Armstrong, Margaret; Doherty, Tom] Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6JB, England.
   [Marks, Michael] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1E 7HT, England.
   [Walker, David] Univ Coll London Hosp, Dept Crit Care, London, England.
RP Doherty, T (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6JB, England.
EM tom.doherty@uclh.nhs.uk
OI Marks, Michael/0000-0002-7585-4743; Walker, David/0000-0002-7140-6855
FU University College London Hospitals Comprehensive Biomedical Research
   Centre Infection Theme; Special Trustees of the Hospital for Tropical
   Diseases; Wellcome Trust Clinical Research Fellow [WT102807]; National
   Institute for Health ResearchNational Institute for Health Research
   (NIHR) [ACF-2012-20-001] Funding Source: researchfish
FX MA is supported by the Special Trustees of the Hospital for Tropical
   Diseases. All authors are supported by the University College London
   Hospitals Comprehensive Biomedical Research Centre Infection Theme. MM
   is a Wellcome Trust Clinical Research Fellow (Grant no. WT102807) at the
   London School of Hygiene and Tropical Medicine. The funding agencies had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Badiaga S, 2005, J EMERG MED, V29, P375, DOI 10.1016/j.jemermed.2005.03.009
   Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872
   Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X
   Blumberg L, 1996, ANAESTH INTENS CARE, V24, P217
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC
   Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236
   Cullen KA, 2013, MMWR SURVEILL SUMM, V62, P1
   Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601
   Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1
   Faiz MA, 2005, LANCET, V366, P717
   GACHOT B, 1995, CHEST, V108, P746, DOI 10.1378/chest.108.3.746
   Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637
   Jennings RM, 2006, AM J TROP MED HYG, V75, P1195, DOI 10.4269/ajtmh.2006.75.1195
   Khoo K. L., 1998, Annals Academy of Medicine Singapore, V27, P353
   Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118
   Nuesch R, 2000, J TRAVEL MED, V7, P95
   SALORD F, 1991, INTENS CARE MED, V17, P449, DOI 10.1007/BF01690765
   Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96
   Schwake L, 2008, CRIT CARE, V12, DOI 10.1186/cc6796
   Thierfelder C, 2008, J TRAVEL MED, V15, P432, DOI 10.1111/j.1708-8305.2008.00251.x
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
NR 22
TC 10
Z9 10
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD MAR 5
PY 2014
VL 13
AR 79
DI 10.1186/1475-2875-13-79
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AC8IN
UT WOS:000332776800002
PM 24602328
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Polley, SD
   Gonzalez, IJ
   Mohamed, D
   Daly, R
   Bowers, K
   Watson, J
   Mewse, E
   Armstrong, M
   Gray, C
   Perkins, MD
   Bell, D
   Kanda, H
   Tomita, N
   Kubota, Y
   Mori, Y
   Chiodini, PL
   Sutherland, CJ
AF Polley, Spencer D.
   Gonzalez, Iveth J.
   Mohamed, Deqa
   Daly, Rosemarie
   Bowers, Kathy
   Watson, Julie
   Mewse, Emma
   Armstrong, Margaret
   Gray, Christen
   Perkins, Mark D.
   Bell, David
   Kanda, Hidetoshi
   Tomita, Norihiro
   Kubota, Yutaka
   Mori, Yasuyoshi
   Chiodini, Peter L.
   Sutherland, Colin J.
TI Clinical Evaluation of a Loop-Mediated Amplification Kit for Diagnosis
   of Imported Malaria
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE malaria; diagnostics; LAMP
ID POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM INFECTION; ISOTHERMAL
   AMPLIFICATION; PARASIGHT(R)-F TEST; MIXED INFECTIONS; DNA; SENSITIVITY;
   PARASITES; BLOOD; UK
AB Background. Diagnosis of malaria relies on parasite detection by microscopy or antigen detection; both fail to detect low-density infections. New tests providing rapid, sensitive diagnosis with minimal need for training would enhance both malaria diagnosis and malaria control activities. We determined the diagnostic accuracy of a new loop-mediated amplification (LAMP) kit in febrile returned travelers.
   Methods. The kit was evaluated in sequential blood samples from returned travelers sent for pathogen testing to a specialist parasitology laboratory. Microscopy was performed, and then malaria LAMP was performed using Plasmodium genus and Plasmodium falciparum-specific tests in parallel. Nested polymerase chain reaction (PCR) was performed on all samples as the reference standard. Primary outcome measures for diagnostic accuracy were sensitivity and specificity of LAMP results, compared with those of nested PCR.
   Results. A total of 705 samples were tested in the primary analysis. Sensitivity and specificity were 98.4% and 98.1%, respectively, for the LAMP P. falciparum primers and 97.0% and 99.2%, respectively, for the Plasmodium genus primers. Post hoc repeat PCR analysis of all 15 tests with discrepant results resolved 4 results in favor of LAMP, suggesting that the primary analysis had underestimated diagnostic accuracy.
   Conclusions. Malaria LAMP had a diagnostic accuracy similar to that of nested PCR, with a greatly reduced time to result, and was superior to expert microscopy.
C1 [Polley, Spencer D.; Mohamed, Deqa; Daly, Rosemarie; Bowers, Kathy; Watson, Julie; Chiodini, Peter L.; Sutherland, Colin J.] Univ London Coll NHS Fdn Trust, Hosp Trop Dis, Dept Clin Parasitol, London, England.
   [Mewse, Emma; Armstrong, Margaret] Univ London Coll NHS Fdn Trust, Hosp Trop Dis, Outpatients Dept, Walk In Clin, London, England.
   [Chiodini, Peter L.; Sutherland, Colin J.] London Sch Hyg & Trop Med, HPA Malaria Reference Lab, London, England.
   [Sutherland, Colin J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England.
   [Gonzalez, Iveth J.; Gray, Christen; Perkins, Mark D.; Bell, David] Fdn Innovat New Diagnost, Geneva, Switzerland.
   [Kanda, Hidetoshi; Tomita, Norihiro; Kubota, Yutaka; Mori, Yasuyoshi] Eiken Chem, Ohtawara, Japan.
RP Sutherland, CJ (corresponding author), Hosp Trop Dis, Dept Clin Parasitol, London WC1E 6JB, England.
EM colin.sutherland@lshtm.ac.uk
RI Sutherland, Colin/AAN-3939-2020
OI Sutherland, Colin/0000-0003-1592-6407; Chiodini,
   Peter/0000-0003-0317-7090
FU Foundation for Innovative New Diagnostics through Bill and Melinda Gates
   Foundation; Ministry of Foreign Affairs of the Government of the
   Netherlands; United Kingdom Department for International Development;
   United Kingdom Health Protection Agency; Special Trustees of the
   Hospital for Tropical Diseases; UCL Hospitals Comprehensive Biomedical
   Research Centre Infection Theme
FX This work was supported by the Foundation for Innovative New
   Diagnostics, through grants from the Bill and Melinda Gates Foundation,
   the Ministry of Foreign Affairs of the Government of the Netherlands,
   and the United Kingdom Department for International Development; the
   United Kingdom Health Protection Agency (to C. J. S.); the Special
   Trustees of the Hospital for Tropical Diseases (to M. A.); and the UCL
   Hospitals Comprehensive Biomedical Research Centre Infection Theme (to
   P. L. C.).
CR [Anonymous], 2011, PLOS MED, V8
   Ayala E, 2006, AM J TROP MED HYG, V74, P546, DOI 10.4269/ajtmh.2006.74.546
   Beshir KB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-312
   Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1
   Chilton D, 2006, J CLIN PATHOL, V59, P862, DOI 10.1136/jcp.2005.032904
   Cox FEG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-5
   Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505
   Farcas GA, 2003, AM J TROP MED HYG, V69, P589, DOI 10.4269/ajtmh.2003.69.6.0690589
   Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264
   Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06
   Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254
   Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927
   Kyriacou DN, 1996, ANN EMERG MED, V27, P696, DOI 10.1016/S0196-0644(96)70186-5
   Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003
   LAVERAN A, 1880, B MEM SOC MED HOP P, V17, P158
   Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572
   Padley DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-139
   Polley SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-62
   Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10
   Poon LLM, 2006, CLIN CHEM, V52, P303
   Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411
   Seringe E, 2011, EMERG INFECT DIS, V17, P807, DOI 10.3201/eid1705.101527
   SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S
   SHIFF CJ, 1994, PARASITOL TODAY, V10, P494, DOI 10.1016/0169-4758(94)90164-3
   Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08
   Smith AD, 2008, BMJ-BRIT MED J, V337, pa120
   SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8
   Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86
   Tsalatsanis A, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-51
   WHO-FIND-CDC-TDR, 2011, MAL RAP DIAGN TEST P
   World Health Organization, 2009, PAR CONF MAL DIAGN W
   World Health Organization (WHO), 2010, GUID TREATM MAL
NR 32
TC 95
Z9 95
U1 0
U2 26
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2013
VL 208
IS 4
BP 637
EP 644
DI 10.1093/infdis/jit183
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 191KO
UT WOS:000322412100013
PM 23633403
OA Bronze, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Logan, S
   Armstrong, M
   Moore, E
   Nebbia, G
   Jarvis, J
   Suvari, M
   Bligh, J
   Chiodini, PL
   Brown, M
   Doherty, T
AF Logan, Sarah
   Armstrong, Margaret
   Moore, Elinor
   Nebbia, Gaia
   Jarvis, Joseph
   Suvari, Muhiddin
   Bligh, John
   Chiodini, Peter L.
   Brown, Michael
   Doherty, Tom
TI Short Report: Acute Schistosomiasis in Travelers: 14 Years' Experience
   at the Hospital for Tropical Diseases, London
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID KATAYAMA FEVER; PRAZIQUANTEL; EFFICACY
AB We report 79 cases of acute schistosomiasis. Most of these cases were young, male travelers who acquired their infection in Lake Malawi. Twelve had a normal eosinophil count at presentation and 11 had negative serology, although two had neither eosinophilia nor positive serology when first seen. Acute schistosomiasis should be considered in any febrile traveler with a history of fresh water exposure in an endemic area once malaria has been excluded.
C1 [Doherty, Tom] Hosp Trop Dis, Mortimer Mkt Ctr, London WC1E 6JB, England.
   Hosp Trop Dis, Mortimer Mkt Ctr, Dept Clin Parasitol, London WC1E 6JB, England.
   London Sch Hyg & Trop Med, London WC1, England.
RP Doherty, T (corresponding author), Hosp Trop Dis, Mortimer Mkt Ctr, Capper St, London WC1E 6JB, England.
EM tom.doherty@uclh.nhs.uk
OI Chiodini, Peter/0000-0003-0317-7090; Jarvis, Joseph/0000-0003-1459-5554
FU Special Trustees of the Hospital for Tropical Diseases; University
   College London Hospitals Comprehensive Biomedical Research Centre,
   Infection Theme; National Institute for Health ResearchNational
   Institute for Health Research (NIHR) [CL-2012-20-001] Funding Source:
   researchfish
FX MA is supported by the Special Trustees of the Hospital for Tropical
   Diseases. All authors are supported by the University College London
   Hospitals Comprehensive Biomedical Research Centre, Infection Theme.
CR Bottieau E, 2006, J INFECTION, V52, P339, DOI 10.1016/j.jinf.2005.07.022
   Clerinx J, 2011, J TRAVEL MED, V18, P367, DOI 10.1111/j.1708-8305.2011.00552.x
   Doherty JF, 1996, BRIT MED J, V313, P1071, DOI 10.1136/bmj.313.7064.1071
   Grandiere-Perez L, 2006, AM J TROP MED HYG, V74, P814, DOI 10.4269/ajtmh.2006.74.814
   Grobusch MP, 2003, J TRAVEL MED, V10, P164, DOI 10.2310/7060.2003.35759
   Han P, 2010, J TRAVEL MED, V17, P316, DOI 10.1111/j.1708-8305.2010.00444.x
   Hou XY, 2008, B WORLD HEALTH ORGAN, V86, P788, DOI 10.2471/BLT.08.053041
   Meltzer E, 2006, EMERG INFECT DIS, V12, P1696, DOI 10.3201/eid1211.060340
   Moore E, 2005, QJM-INT J MED, V98, P69, DOI 10.1093/qjmed/hci010
   Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729
   Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1
   Tanaka H, 1997, INT J PARASITOL, V27, P1465, DOI 10.1016/S0020-7519(97)00183-5
   TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2
NR 13
TC 14
Z9 15
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2013
VL 88
IS 6
BP 1032
EP 1034
DI 10.4269/ajtmh.12-0646
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 158GO
UT WOS:000319957700004
PM 23530076
OA Green Published, Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Marks, ME
   Armstrong, M
   Suvari, MM
   Batson, S
   Whitty, CJM
   Chiodini, PL
   Bellinghan, G
   Doherty, JF
AF Marks, Michael E.
   Armstrong, Margaret
   Suvari, Muhiddin M.
   Batson, Steve
   Whitty, Christopher J. M.
   Chiodini, Peter L.
   Bellinghan, Geoff
   Doherty, Justin F.
TI Severe imported falciparum malaria among adults requiring intensive
   care: a retrospective study at the hospital for tropical diseases,
   London
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID INTRAVENOUS ARTESUNATE; RISK-FACTORS; UNIT; SURVEILLANCE; HIV
AB Background: Malaria is the commonest imported infection in the UK. Malaria requiring ICU admission has a reported mortality of up to 25%. The relationship between ethnicity, immunity, and risk of malaria is complex. The Malaria Score for Adults (MSA) and Coma Acidosis Malaria (CAM) score have recently been proposed to risk stratify patients with malaria.
   Methods: Retrospective study of patients with WHO severe falciparum malaria admitted to ICU at the Hospital for Tropical Diseases, London, UK. The relationship between clinical variables and risk of death or a prolonged ICU stay were examined with logistic regression. The predictive value of the MSA and CAM score were calculated.
   Results: 124 patients were included. Cerebral malaria and acute kidney injury occurred earlier (median day 1) than acute respiratory distress syndrome (median day 3). Six patients had community acquired bacterial co-infection. Eight patients were co-infected with HIV, five of whom were newly diagnosed. The positive predictive value of a CAM score >= 2 or an MSA >= 5 for death were 12% and 22% respectively. Five patients died. No variable was significantly associated with risk of death. There were no significant differences between individuals raised in endemic countries compared to non-endemic countries.
   Conclusions: Mortality in patients managed in a specialist centre was low. Patients who died succumbed to complications associated with a prolonged stay on ICU rather than malaria per se. The clinical usefulness of the MSA and CAM score was limited. Co-infection with HIV was relatively common but compared to studies in children, bacteraemia was uncommon. The relationship between ethnicity and immunity to severe disease is complex.
C1 [Marks, Michael E.; Armstrong, Margaret; Whitty, Christopher J. M.; Doherty, Justin F.] Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6JB, England.
   [Suvari, Muhiddin M.; Chiodini, Peter L.] Hosp Trop Dis, Mortimer Market Ctr, Dept Clin Parasitol, London WC1E 6JB, England.
   [Batson, Steve; Bellinghan, Geoff] Univ Coll London Hosp, Intens Care Unit, London NW1, England.
RP Doherty, JF (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6JB, England.
EM tom.doherty@uclh.nhs.uk
OI Chiodini, Peter/0000-0003-0317-7090; Marks, Michael/0000-0002-7585-4743;
   Whitty, Christopher/0000-0002-6076-5027
FU Special Trustees of the Hospital for Tropical Diseases; The Special
   Trustees of the Hospital for Tropical Diseases; University College
   London Hospitals Comprehensive Biomedical Research Centre Infection
   Theme; National Institute for Health ResearchNational Institute for
   Health Research (NIHR) [ACF-2012-20-001] Funding Source: researchfish
FX This study was supported by the Special Trustees of the Hospital for
   Tropical Diseases. Margaret Armstrong is supported by The Special
   Trustees of the Hospital for Tropical Diseases. All authors are
   supported by the University College London Hospitals Comprehensive
   Biomedical Research Centre Infection Theme. The funding agencies had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Badiaga S, 2005, J EMERG MED, V29, P375, DOI 10.1016/j.jemermed.2005.03.009
   Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
   Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X
   Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F
   Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8
   Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC
   Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236
   Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116
   Faiz MA, 2005, LANCET, V366, P717
   Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637
   Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928
   Jennings RM, 2006, AM J TROP MED HYG, V75, P1195, DOI 10.4269/ajtmh.2006.75.1195
   Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-102
   Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003
   Mali Sonja, 2012, Morbidity and Mortality Weekly Report, V61, P1
   MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102
   Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24
   Morch K, 2008, EMERG INFECT DIS, V14, P1816, DOI 10.3201/eid1411.080636
   Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x
   Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258
   Reithinger R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2141
   Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96
   Schwake L, 2008, CRIT CARE, V12, DOI 10.1186/cc6796
   Seringe E, 2011, EMERG INFECT DIS, V17, P807, DOI 10.3201/eid1705.101527
   Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120
   Thierfelder C, 2008, J TRAVEL MED, V15, P432, DOI 10.1111/j.1708-8305.2008.00251.x
   Zoller T, 2011, EMERG INFECT DIS, V17, P771, DOI 10.3201/eid1705.101229
NR 27
TC 32
Z9 33
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 5
PY 2013
VL 13
AR 118
DI 10.1186/1471-2334-13-118
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 103HB
UT WOS:000315905300001
PM 23497139
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Armstrong, M
   Ndiaye, A
   Razanatsimba, R
   Galli, A
AF Armstrong, Margaret
   Ndiaye, Aziz
   Razanatsimba, Rija
   Galli, Alain
TI Scenario Reduction Applied to Geostatistical Simulations
SO MATHEMATICAL GEOSCIENCES
LA English
DT Article
DE Stochastic optimization; Multi-stage programming with recourse
ID UNCERTAINTY; OPTIMIZATION; DISTANCES
AB Having a large number of geostatistical simulations of a mineral or petroleum deposit provides a better idea of its upside potential and downside risk; however, large numbers of simulated realizations of a deposit may pose computational difficulties in subsequent decision-making phases. Hence, depending on the specific case, there can be a need to select a representative subset of conditionally simulated deposit realizations. This paper examines and extends an approach developed by the stochastic optimization community based on stochastic mathematical programming with recourse and is discussed here in the context of mineral deposits while it is possibly suitable for other earth science applications. The approach is based on measuring the "distance" between simulations and the introduced distance measure between simulated realizations of a mineral deposit is based on the metal above a given set of cutoff grades while a pre-existing mine design is available. The approach is tested on 100 simulations of the Walker Lake data with promising results.
C1 [Armstrong, Margaret; Ndiaye, Aziz; Razanatsimba, Rija; Galli, Alain] Mines Paris, Cerna, F-75272 Paris, France.
RP Armstrong, M (corresponding author), Mines Paris, Cerna, 60 Blvd St Michel, F-75272 Paris, France.
EM margaret.armstrong@mines-paristech.fr
FU Research Consortium on the Real Options in Mining; Codelco (Chile)
FX This work was funded by the Research Consortium on the Real Options in
   Mining. The authors would like to thank the sponsors: Codelco (Chile)
   and two multinational mining companies for their support and
   encouragement during the 2 year project. Thanks are also due to the
   three referees for their constructive comments.
CR Armstrong M, 2009, P PROJ EV C ORG AUSI
   Armstrong M, 2011, 35 APCOM S HELD WOLL
   Arpat BG, 2005, THESIS STANFORD U US
   Baudat G, 2000, NEURAL COMPUT, V12, P2385, DOI 10.1162/089976600300014980
   Baudat G, 2003, NEUROCOMPUTING, V55, P21, DOI 10.1016/S0925-2312(03)00429-6
   Beasley JE, 2010, OR NOTES
   Bleines C, 2006, ISATIS 6 0 CASE STUD
   Consuegra FRA, 2009, T I MIN METALL A, V118, P79, DOI 10.1179/037178409X12541250836860
   DERMAN E, 1996, GOLDMAN SACHS QUANTI
   Dupacova J, 2003, MATH PROGRAM, V95, P493, DOI 10.1007/s10107-002-0331-0
   Growe-Kuska N, 2003, IEEEE BOL POW TECH P
   Heitsch H, 2006, SIAM J OPTIMIZ, V17, P511, DOI 10.1137/050632865
   Heitsch H, 2003, COMPUT OPTIM APPL, V24, P187, DOI 10.1023/A:1021805924152
   Heitsch H, 2009, MATH PROGRAM, V118, P371, DOI 10.1007/s10107-007-0197-2
   Isaaks E. H., 1989, INTRO APPL GEOSTATIS
   John Hull, 2009, OPTIONS FUTURES OTHE
   Journel AG, 1994, ENVIRON ECOL STAT, V1, P63, DOI 10.1007/BF00714200
   Kall P, 2005, SPRINGER INT SERIES
   Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616
   Matheron G, 1975, 134 CTR GEOST
   QURESHI S, 2004, GEOSTATISTICS BANFF, V2, P959
   Rachev ST, 1991, PROBABILITY METRICS
   Rockafellar RT, 2004, VARIATIONAL ANAL
   Romisch W, 2007, SPRING SCH STOCHASTI
   Sahinidis NV, 2004, COMPUT CHEM ENG, V28, P971, DOI 10.1016/j.compchemeng.2003.09.017
   Scheidt C, 2009, SPE J, V14, P680, DOI 10.2118/118740-PA
   Scheidt C, 2009, MATH GEOSCI, V41, P397, DOI 10.1007/s11004-008-9186-0
   Suzuki S, 2008, MATH GEOSCI, V40, P445, DOI 10.1007/s11004-008-9154-8
   VANDERVLERK MH, 1996, STOCHASTIC PROGRAMMI
   WEBER D, 1992, MATH GEOL, V24, P381, DOI 10.1007/BF00891270
NR 30
TC 23
Z9 29
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1874-8961
EI 1874-8953
J9 MATH GEOSCI
JI Math Geosci.
PD FEB
PY 2013
VL 45
IS 2
BP 165
EP 182
DI 10.1007/s11004-012-9420-7
PG 18
WC Geosciences, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Geology; Mathematics
GA 094PI
UT WOS:000315275900003
DA 2020-12-01
ER

PT J
AU Roberts, CH
   Armstrong, M
   Zatyka, E
   Boadi, S
   Warren, S
   Chiodini, PL
   Sutherland, CJ
   Doherty, T
AF Roberts, Catherine H.
   Armstrong, Margaret
   Zatyka, Ewa
   Boadi, Samuel
   Warren, Simon
   Chiodini, Peter L.
   Sutherland, Colin J.
   Doherty, Tom
TI Gametocyte carriage in Plasmodium falciparum-infected travellers
SO MALARIA JOURNAL
LA English
DT Article
DE Falciparum malaria; Gametocytes; Adult travellers
ID RISK-FACTORS; BURKINA-FASO; MALARIA; CHILDREN; EPIDEMIOLOGY;
   TRANSMISSION; INFECTIVITY; MOSQUITOS; IMMUNITY; DRUGS
AB Background: Gametocytes are the sexual stage of Plasmodium parasites. The determinants of gametocyte carriage have been studied extensively in endemic areas, but have rarely been explored in travellers with malaria. The incidence of gametocytaemia, and factors associated with gametocyte emergence in adult travellers with Plasmodium falciparum malaria was investigated at the Hospital for Tropical Diseases in London.
   Methods: Clinical, parasitological and demographic data for all patients presenting with P. falciparum malaria between January 2001 and December 2011 were extracted from a prospective database. These data were supplemented by manual searches of laboratory records and patient case notes.
   Results: Seven hundred and seventy three adult patients with laboratory-confirmed P. falciparum malaria were identified. Four hundred and sixty five (60%) were born in a country where malaria is endemic. Patients presented to hospital a median of four days into their illness. The median maximum parasite count was 0.4%. One hundred and ninety six patients (25%) had gametocytes; 94 (12%) on admission, and 102 (13%) developing during treatment. Gametocytaemia on admission was associated with anaemia and a lower maximum parasitaemia. Patients with gametocytes at presentation were less likely to have thrombocytopenia or severe malaria. Patients who developed gametocytes during treatment were more likely to have had parasitaemia of long duration, a high maximum parasitaemia and to have had severe malaria. There was no apparent association between the appearance of gametocytes and treatment regimen.
   Conclusions: The development of gametocytaemia in travellers with P. falciparum is associated with factors similar to those reported among populations in endemic areas. These data suggest that acquired immunity to malaria is not the only determinant of patterns of gametocyte carriage among patients with the disease.
C1 [Roberts, Catherine H.; Armstrong, Margaret; Zatyka, Ewa; Warren, Simon; Chiodini, Peter L.; Doherty, Tom] Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6JB, England.
   [Boadi, Samuel; Chiodini, Peter L.; Sutherland, Colin J.] Hosp Trop Dis, Mortimer Market Ctr, Dept Clin Parasitol, London WC1E 6JB, England.
   [Chiodini, Peter L.; Sutherland, Colin J.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England.
RP Doherty, T (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6JB, England.
EM tom.doherty@uclh.nhs.uk
RI Sutherland, Colin/AAN-3939-2020
OI Sutherland, Colin/0000-0003-1592-6407; Boadi,
   Samuel/0000-0002-2345-0210; Roberts, Catherine/0000-0002-1746-7681;
   Roberts, Chrissy h./0000-0003-1064-5980; Chiodini,
   Peter/0000-0003-0317-7090
FU Special Trustees of the Hospital for Tropical Diseases; University
   College London Hospitals Comprehensive Biomedical Research Centre
   Infection Theme; UK Health Protection Agency
FX This study was supported by the Special Trustees of the Hospital for
   Tropical Diseases and the University College London Hospitals
   Comprehensive Biomedical Research Centre Infection Theme. MA is
   supported by The Special Trustees of the Hospital for Tropical Diseases.
   CJS is supported by the UK Health Protection Agency. The funding
   agencies had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069
   BOUDIN C, 1991, ANN TROP MED PARASIT, V85, P377, DOI 10.1080/00034983.1991.11812580
   Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911
   Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P131, DOI 10.1046/j.1365-3156.1999.00361.x
   GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P479, DOI 10.4269/ajtmh.1991.45.479
   Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015
   Ouedraogo AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-281
   Paul RE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-123
   Peatey CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-34
   Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019
   Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280
   Sowunmi A, 2004, PARASITOLOGY, V129, P255, DOI 10.1017/S0031182004005669
   Sowunmi A, 2011, CHEMOTHERAPY, V57, P497, DOI 10.1159/000334126
   Stepniewska K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-249
   Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578
NR 17
TC 6
Z9 6
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 24
PY 2013
VL 12
AR 31
DI 10.1186/1475-2875-12-31
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 118YI
UT WOS:000317062800002
PM 23347669
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU Marks, M
   Pollock, E
   Armstrong, M
   Morris-Jones, S
   Kidd, M
   Gothard, P
   Noursadeghi, M
   Doherty, JF
AF Marks, Michael
   Pollock, Emily
   Armstrong, Margaret
   Morris-Jones, Stephen
   Kidd, Michael
   Gothard, Philip
   Noursadeghi, Mahdad
   Doherty, Justin F.
TI Needles and the damage done: Reasons for admission and financial costs
   associated with injecting drug use in a Central London Teaching Hospital
SO JOURNAL OF INFECTION
LA English
DT Article
DE Blood-borne viruses; Injecting drug use; Substance misuse; Skin and soft
   tissue infections; Cost
ID INFECTIONS; IMPACT; ENGLAND; CARE
AB Objectives: To establish the clinical reasons for inpatient admissions among injecting drug users. To determine the frequency of behavioural issues during their care and to estimate the financial implications of injecting drug use to the health service.
   Methods: Retrospective cohort study at University College London Hospital. Clinical, laboratory and financial data were extracted from case notes and electronic records. The cost of each admission was compared to the income received for the period of care.
   Results: 124 injecting drug users required 191 admissions between 2005 and 2009. Skin and soft tissue infections (58%) and pneumonia (18%) were the commonest reasons for admission. Bacteraemia at admission was often not accompanied by an inflammatory response. Exposure to HIV (4%), hepatitis B (49%) and C (84%) was common. Drug misuse (16%) during admission was frequent. The cost to the NHS of treating soft tissue infections in drug users was approximately 77 pound million per annum. After a median follow-up of 40 months, 10 patients (8%) had died. All deaths were attributable to drug use.
   Conclusions: Bacterial and viral infections are largely responsible for the significant mortality and morbidity of injecting drug users presenting to secondary care. The financial burden to the NHS is substantial. (C) 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Marks, Michael; Pollock, Emily; Armstrong, Margaret; Gothard, Philip; Doherty, Justin F.] Univ Coll London Hosp, Hosp Trop Dis, London WC1E 6JB, England.
   [Morris-Jones, Stephen] Univ Coll London Hosp, Dept Microbiol, London NW1 2BU, England.
   [Kidd, Michael] Univ Coll London Hosp, Dept Virol, London NW1 2BU, England.
   [Noursadeghi, Mahdad] UCL, Div Infect & Immun, London WC1E 6BT, England.
RP Doherty, JF (corresponding author), Univ Coll London Hosp, Hosp Trop Dis, Capper St, London WC1E 6JB, England.
EM tom.doherty@uclh.nhs.uk
OI Marks, Michael/0000-0002-7585-4743; Noursadeghi,
   Mahdad/0000-0002-4774-0853
FU Department of Health's NIHR Biomedical Research CentreNational Institute
   for Health Research (NIHR); National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [ACF-2012-20-001]
   Funding Source: researchfish
FX This work was undertaken at UCLH/UCL who received a proportion of
   funding from the Department of Health's NIHR Biomedical Research Centres
   funding scheme. MA was supported by the Special Trustees of the Hospital
   for Tropical Diseases.
CR Atkinson SR, 2009, J INFECTION, V58, P339, DOI 10.1016/j.jinf.2009.03.004
   Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168
   Beaufoy A, 1993, Can J Infect Control, V8, P7
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   British HIV Association, 2008, NAT GUID HIV TEST
   Hay G, 2009, STAT METHODS MED RES, V18, P323, DOI 10.1177/0962280208094687
   Health Protection Agency, 2011, UNL AN HIV VIR HEP M
   Hope V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-120
   Hope VD, 2012, AM J PUBLIC HEALTH, V102, P122, DOI 10.2105/AJPH.2011.300314
   Huang H, 2008, DIAGN MICR INFEC DIS, V60, P347, DOI 10.1016/j.diagmicrobio.2007.11.001
   Islam MM, 2012, INT J DRUG POLICY, V23, P94, DOI 10.1016/j.drugpo.2011.08.005
   Lamagni TL, 2008, CLIN MICROBIOL INFEC, V14, P1002, DOI 10.1111/j.1469-0691.2008.02076.x
   Mertz D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-42
   Miller M, 2003, EUR J CLIN MICROBIOL, V22, P463, DOI 10.1007/s10096-003-0969-4
   Palepu A, 2001, CAN MED ASSOC J, V165, P415
   Schroeter M, 2009, EPIDEMIOL INFECT, V137, P1602, DOI 10.1017/S0950268809002544
   Takahashi TA, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-006-0079-y
   Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x
NR 18
TC 23
Z9 23
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
J9 J INFECTION
JI J. Infect.
PD JAN
PY 2013
VL 66
IS 1
BP 95
EP 102
DI 10.1016/j.jinf.2012.10.004
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 052IJ
UT WOS:000312190900012
PM 23068454
DA 2020-12-01
ER

PT J
AU Wise, ES
   Armstrong, MS
   Watson, J
   Lockwood, DN
AF Wise, Emily S.
   Armstrong, Margaret S.
   Watson, Julie
   Lockwood, Diana N.
TI Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in
   the Day-Case Management of Returned Travellers with New World Cutaneous
   Leishmaniasi
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CONTROLLED CLINICAL-TRIAL; EFFICACY; THERAPY; SAFETY; MUCOSAL
AB Background: Patients with New World cutaneous leishmaniasis (NWCL) caused by Leishmania Viannia are treated with parenteral sodium stibogluconate (SbV) to reduce the risk of development of mucocutanous leishmaniasis. Our centre manages patients with NWCL on an outpatient-basis. This study was conducted to assess the safety and efficacy of this approach.
   Methodology: We reviewed records of 67 consecutive NWCL patients, aged 17-61 years, treated as day-cases with 20 mg/kg/day SbV for up to 28 days at our UK centre. Data had been collected in a standardised format at the time of treatment using a care-record tool. Patients reported adverse-effects daily using a structured questionnaire. Blood tests and electrocardiograms were performed twice weekly to monitor for toxicity.
   Principal Findings: Parenteral SbV treatment was associated with an early, significant suppression of mean lymphocyte and platelet counts. By day four of treatment, lymphocytes reduced by 0.53x10(9)/L (CI 0.29x10(9)/L to 0.76x10(9)/L, p<0.001), and platelets by 31,000/mu L (CI 16,000/mu L to 46,000/mu L, p<0.001). SbV was further associated with significant elevation of serum alanine transaminase concentrations, with a mean peak rise of 107 iu/L by day 13 (CI 52 iu/L to 161 iu/L, p<0.001). These disturbances were temporary and did not result in adverse clinical events. Patient-described symptoms were cumulative and at three weeks of treatment, 59.6% of patients experienced myalgia and 29.8% malaise. Treatment adherence and clinical outcomes were comparable to inpatient treatment studies. A total of 1407 individual doses of SbV resulted in only 26 nights' hospital admission, a saving of 1381 bed-days compared to inpatient treatment.
   Conclusions/Significance: In specialist centres, NWCL patients aged below 65 years and without co-morbidities can be safely and effectively treated without hospital admission. This reduces the cost of treatment, and is much preferred by patients. Twice weekly blood and electrocardiographic monitoring may be surplus to requirement in clinically well, low-risk patients.
C1 [Wise, Emily S.; Watson, Julie] Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Dept Parasitol, London, England.
RP Wise, ES (corresponding author), Univ Coll London Hosp NHS Trust, Hosp Trop Dis, Dept Parasitol, London, England.
EM emilywise@doctors.org.uk
CR Aronson NE, 1998, CLIN INFECT DIS, V27, P1457, DOI 10.1086/515027
   Bailey M S, 2005, J R Army Med Corps, V151, P73
   BALLOU WR, 1987, LANCET, V2, P13
   Brostoff JM, 2012, J CLIN PHARM THER, V37, P122, DOI 10.1111/j.1365-2710.2011.01259.x
   BRYCESON ADM, 1985, T ROY SOC TROP MED H, V79, P705, DOI 10.1016/0035-9203(85)90199-3
   Chrusciak-Talhari A, 2011, AM J TROP MED HYG, V84, P255, DOI 10.4269/ajtmh.2011.10-0155
   CHULAY JD, 1985, AM J TROP MED HYG, V34, P702, DOI 10.4269/ajtmh.1985.34.702
   DAVID C, 1993, T ROY SOC TROP MED H, V87, P7, DOI 10.1016/0035-9203(93)90398-A
   Davidson RN, 1998, DRUGS, V56, P1009, DOI 10.2165/00003495-199856060-00005
   Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004
   GASSER RA, 1994, CLIN INFECT DIS, V18, P83, DOI 10.1093/clinids/18.1.83
   Hartzell JD, 2006, AM J TROP MED HYG, V74, P591, DOI 10.4269/ajtmh.2006.74.591
   HEPBURN NC, 1993, T ROY SOC TROP MED H, V87, P691, DOI 10.1016/0035-9203(93)90298-5
   HEPBURN NC, 1993, LANCET, V342, P238, DOI 10.1016/0140-6736(93)92327-P
   HEPBURN NC, 1994, Q J MED, V87, P465
   HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296
   Lawn SD, 2006, T ROY SOC TROP MED H, V100, P264, DOI 10.1016/j.trstmh.2005.03.012
   Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127
   Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912
   MCBRIDE MO, 1995, CLIN INFECT DIS, V21, P710, DOI 10.1093/clinids/21.3.710
   NAVIN TR, 1990, AM J TROP MED HYG, V42, P43, DOI 10.4269/ajtmh.1990.42.43
   Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007
   Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
   SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L
   Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659
   WHO, 2010, M WHO EXP COMM CONTR
   Wortmann G, 2002, CLIN INFECT DIS, V35, P261, DOI 10.1086/341406
   Wortmann GW, 1998, CLIN INFECT DIS, V27, P509, DOI 10.1086/514689
NR 28
TC 16
Z9 16
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2012
VL 6
IS 6
AR e1688
DI 10.1371/journal.pntd.0001688
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 967YY
UT WOS:000305945300030
PM 22745840
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU Wall, EC
   Watson, J
   Armstrong, M
   Chiodini, PL
   Lockwood, DN
AF Wall, Emma C.
   Watson, Julie
   Armstrong, Margaret
   Chiodini, Peter L.
   Lockwood, Diana N.
TI Short Report: Epidemiology of Imported Cutaneous Leishmaniasis at the
   Hospital for Tropical Diseases, London, United Kingdom: Use of
   Polymerase Chain Reaction to Identify the Species
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CLINICAL-SAMPLES; PCR-RFLP; DIAGNOSIS; IDENTIFICATION
AB This study reviewed all patients diagnosed with imported cutaneous leishmaniasis (CL) at the Hospital for Tropical Diseases in London, United Kingdom, over an 11-year period. Diagnostic and epidemiologic information was collected prospectively for all patients with imported CL to this hospital during 1998-2009. A total of 223 patients were given a diagnosis of CL. Ninety patients were diagnosed with Old World CL, which was caused most commonly by Leishmania donovani complex (n = 20). A total of 71% were tourists to the Mediterranean region, 36% were migrants or visiting friends and relatives, and 11.7% were soldiers. One hundred thirty-three patients were given a diagnosis of New World CL. The Leishmania subgenus Viannia caused 97 of these cases; 44% of these were in backpackers and 29% were in soldiers. Polymerase chain reaction was more sensitive and faster for detecting Leishmania DNA (86% for Old World CL and 96% for New World CL) than culture. This is the largest study of imported leishmaniasis, and demonstrates that tourists to the Mediterranean and backpackers in Central and South America are at risk for this disease.
C1 [Wall, Emma C.; Watson, Julie; Chiodini, Peter L.; Lockwood, Diana N.] Hosp Trop Dis, Mortimer Market Ctr, Dept Clin Parasitol, London WC1E 6JB, England.
   [Chiodini, Peter L.; Lockwood, Diana N.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Wall, EC (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Dept Clin Parasitol, Capper St, London WC1E 6JB, England.
EM emma.wall@doctors.org.uk; Julie.Watson@uclh.nhs.uk;
   Margaret.Armstrong@uclh.nhs.uk; Peter.Chiodini@uclh.nhs.uk;
   Diana.Lockwood@lshtm.ac.uk
OI Wall, Emma/0000-0003-2732-4497; Chiodini, Peter/0000-0003-0317-7090
FU Hospital for Tropical Diseases; University College London Hospitals
   Comprehensive Biomedical Research Centre Infection Theme
FX This study was supported by the Special Trustees of the Hospital for
   Tropical Diseases, Margaret Armstrong is supported by The Special
   Trustees of the Hospital for Tropical Diseases. All authors are
   supported by the University College London Hospitals Comprehensive
   Biomedical Research Centre Infection Theme. The funding agencies had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akkafa F, 2008, PARASITOL RES, V103, P583, DOI 10.1007/s00436-008-1013-5
   Al-Hucheimi SN, 2009, INT J DERMATOL, V48, P404, DOI 10.1111/j.1365-4632.2009.03903.x
   Antoniou M, 2009, LANCET INFECT DIS, V9, P76, DOI 10.1016/S1473-3099(09)70004-0
   Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008
   Benmously-Mlika R, 2008, ANN DERMATOL VENER, V135, P389, DOI 10.1016/j.annder.2007.10.006
   Bhutto AM, 2009, ACTA TROP, V111, P295, DOI 10.1016/j.actatropica.2009.05.009
   Campino L, 2006, TROP MED INT HEALTH, V11, P1708, DOI 10.1111/j.1365-3156.2006.01728.x
   DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J
   Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981
   Faber W R, 1991, Ned Tijdschr Geneeskd, V135, P229
   Faber WR, 2003, J AM ACAD DERMATOL, V49, P70, DOI 10.1067/mjd.2003.492
   Gadisa E, 2007, EXP PARASITOL, V115, P339, DOI 10.1016/j.exppara.2006.09.014
   Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011
   Katakura K, 2009, CURR OPIN INFECT DIS, V22, P126, DOI 10.1097/QCO.0b013e3283229ff2
   Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127
   Noyes HA, 1998, J CLIN MICROBIOL, V36, P2877, DOI 10.1128/JCM.36.10.2877-2881.1998
   Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
   Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06
   Rhajaoui M, 2007, EMERG INFECT DIS, V13, P1358, DOI 10.3201/eid1309.060946
   Scarisbrick J J, 2006, Travel Med Infect Dis, V4, P14, DOI 10.1016/j.tmaid.2004.11.002
   Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659
   Zeegelaar JE, 2005, CLIN EXP DERMATOL, V30, P1, DOI 10.1111/j.1365-2230.2004.01677.x
NR 22
TC 24
Z9 24
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JAN
PY 2012
VL 86
IS 1
BP 115
EP 118
DI 10.4269/ajtmh.2012.10-0558
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 875WF
UT WOS:000299065200023
PM 22232460
OA Green Published, Bronze, Green Accepted
DA 2020-12-01
ER

PT J
AU Patel, TA
   Armstrong, M
   Morris-Jones, SD
   Wright, SG
   Doherty, T
AF Patel, Trupti A.
   Armstrong, Margaret
   Morris-Jones, Stephen D.
   Wright, Stephen G.
   Doherty, Tom
TI Imported Enteric Fever: Case Series from the Hospital for Tropical
   Diseases, London, United Kingdom
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TYPHOID-FEVER; SALMONELLA-ENTERICA; PARATYPHOID FEVER; SEROVAR TYPHI;
   TRAVELERS; CHILDREN; NEPAL; HEPATITIS; SURVEILLANCE; CEFTRIAXONE
AB Our current knowledge of the clinical characteristics of enteric fever is drawn mainly from population-based studies in disease-endemic countries, and there are limited data published on cases in returning travelers. We report the clinical characteristics of enteric fever in 92 travelers returning to London, United Kingdom. Salmonella typhi and S. paratyphi resulted in an almost indistinguishable clinical picture. Rose spots and relative bradycardia were found only in a few patients. A total of 91% of the patients had a normal leukocyte count, which was associated with a markedly increased level of alanine aminotransferase in 82%. A total of 57% of the S. typhi isolates had decreased susceptibility to ciprofloxacin and resistance to nalidixic acid; these isolates were from southern Asia. Thirty percent were multidrug resistant; all were from southern Asia and Nigeria. None of the paratyphoid isolates were multidrug resistant but rates of decreased susceptibility to fluoroquinolones were higher than in S. typhi (74%).
C1 [Patel, Trupti A.; Armstrong, Margaret; Wright, Stephen G.; Doherty, Tom] Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6JB, England.
   Univ Coll London Hosp, Dept Clin Microbiol, London, England.
   London Sch Hyg & Trop Med, London WC1, England.
   [Morris-Jones, Stephen D.] Windeyer Inst Med Sci, Dept Clin Microbiol, London, England.
RP Patel, TA (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6JB, England.
EM trupti@doctors.org.uk
CR Ackers ML, 2000, JAMA-J AM MED ASSOC, V283, P2668, DOI 10.1001/jama.283.20.2668
   Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013
   BEHRENS R, 2003, 8 C INT TRAV MED 200
   Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4
   Clark TW, 2010, J INFECTION, V60, P91, DOI 10.1016/j.jinf.2009.11.009
   Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5
   Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005
   Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
   Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x
   Dutta P, 2001, INDIAN J MED RES, V113, P210
   Ekdahl K, 2005, J TRAVEL MED, V12, P197, DOI 10.2310/7060.2005.12405
   ElNewihi HM, 1996, HEPATOLOGY, V24, P516, DOI 10.1053/jhep.1996.v24.pm0008781316
   *ENT FEV ENGL WAL, 1991, COMMUN DIS REP LOND, V1, P371
   *ENT FEV ENGL WAL, 1981, COMMUN DIS REP LOND, V1, P371
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   GOH K T, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P55
   Hardy A., 1993, EPIDEMIC STREETS INF
   Health Protection Agency, 2006, PIL ENH SURV ENT FEV
   Health Protection Agency, 2009, SALM TYPH SALM PAR L
   IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957
   Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033
   Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003
   Meltzer E, 2007, ISRAEL MED ASSOC J, V9, P736
   Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670
   Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168
   Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201
   Parry CM, 2003, CURR OPIN INFECT DIS, V16, P467, DOI 10.1097/00001432-200310000-00014
   Provost S, 2006, J TRAVEL MED, V13, P219, DOI 10.1111/j.1708-8305.2006.00031.x
   Rodrigues C, 2003, CLIN INFECT DIS, V36, P535, DOI 10.1086/367644
   SCHWARTZ E, 1990, Archives of Internal Medicine, V150, P349, DOI 10.1001/archinte.150.2.349
   Shetty AK, 1999, J TROP PEDIATRICS, V45, P287, DOI 10.1093/tropej/45.5.287
   Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1
   STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84
   Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945
   Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10
   Tatli MM, 2003, INT J ANTIMICROB AG, V21, P350, DOI 10.1016/S0924-8579(02)00388-6
   Thaver D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1865
   Threlfall EJ, 2006, LANCET, V367, P1576, DOI 10.1016/S0140-6736(06)68691-1
   Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012
   Vollaard AM, 2004, EPIDEMIOL INFECT, V132, P863, DOI 10.1017/S0950268804002742
   Wain J, 1999, J CLIN MICROBIOL, V37, P2466, DOI 10.1128/JCM.37.8.2466-2472.1999
   Walia M, 2006, T ROY SOC TROP MED H, V100, P942, DOI 10.1016/j.trstmh.2006.02.015
   *WHO, TYPH VACC IN VACC RE
NR 43
TC 37
Z9 37
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2010
VL 82
IS 6
BP 1121
EP 1126
DI 10.4269/ajtmh.2010.10-0007
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 606XP
UT WOS:000278462600026
PM 20519611
OA Green Published, Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Cosgrove, C
   Brown, M
   Armstrong, M
   Doherty, J
AF Cosgrove, Catherine
   Brown, Michael
   Armstrong, Margaret
   Doherty, Justin
TI ACUTE HEPATITIS E IS MORE COMMON THAN HEPATITIS A AMONG RETURNING
   TRAVELLERS PRESENTING TO SECONDARY CARE
SO JOURNAL OF INFECTION
LA English
DT Meeting Abstract
C1 [Cosgrove, Catherine; Brown, Michael; Armstrong, Margaret; Doherty, Justin] Hosp Trop Dis, London NW1 0PE, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
J9 J INFECTION
JI J. Infect.
PD DEC
PY 2009
VL 59
IS 6
MA 0044
BP S447
EP S448
DI 10.1016/j.jinf.2009.10.041
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA 545EG
UT WOS:000273714700046
DA 2020-12-01
ER

PT J
AU Jennings, RM
   De Souza, JB
   Todd, JE
   Armstrong, M
   Flanagan, KL
   Riley, EM
   Doherty, JF
AF Jennings, Richard M.
   De Souza, J. Brian
   Todd, Jim E.
   Armstrong, Margaret
   Flanagan, Katie L.
   Riley, Eleanor M.
   Doherty, Justin F.
TI Imported Plasmodium falciparum malaria: Are patients originating from
   disease-endemic areas less likely to develop severe disease? A
   prospective, observational study
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NECROSIS FACTOR; IMMUNITY
AB Just more than 2,000 cases of Plasmodium falciparum malaria are reported in the United Kingdom annually, with a mortality rate of approximately 1%. Some studies suggest that patients with malaria who originate from disease-endemic areas are less likely to develop severe disease; such patients are often treated at home. We have prospectively examined 99 patients with imported P. falciparum malaria and categorized them according to severity as defined by World Health Organization criteria. There was no significant difference between those who developed severe disease and those who did not in terms of their ethnicity, residence in a malaria-endemic area, or history of previous episodes of malaria. To assume a patient has clinical immunity to malaria simply because they originate from or have lived for a long time in a malaria-endemic area may be inappropriate and unsafe.
C1 Hosp Trop Dis, London WC1E 6AU, England.
   London Sch Hyg & Trop Med, London WC1, England.
RP Doherty, JF (corresponding author), Hosp Trop Dis, Mortimer Market,Capper St, London WC1E 6AU, England.
EM tom.doherty@uclh.org
RI Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; de Souza,
   Joseph B/D-4979-2009
OI Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor
   M/0000-0003-3447-3570; 
CR Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x
   Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1
   Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21
   Bradley D.J., 1998, Euro Surveill, V3, P40
   Chaput de Saintonge DM, 1974, LANCET, V1, P120
   D'Acremont V, 2002, BRIT MED J, V324, P875, DOI 10.1136/bmj.324.7342.875
   Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016
   Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404
   Jensenius M, 1999, SCAND J INFECT DIS, V31, P73, DOI 10.1080/00365549950161925
   Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616
   Kwiatkowski D, 1997, ANN TROP MED PARASIT, V91, P533, DOI 10.1080/00034989760905
   KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5
   Marsh K., 2002, ESSENTIAL MALARIOLOG, P252
   May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857
   Rhee MSM, 2001, CLIN EXP IMMUNOL, V126, P503, DOI 10.1046/j.1365-2249.2001.01681.x
   Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x
NR 18
TC 27
Z9 27
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2006
VL 75
IS 6
BP 1195
EP 1199
DI 10.4269/ajtmh.2006.75.1195
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 117OC
UT WOS:000242881600033
PM 17172392
OA Green Accepted, Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Lawn, SD
   Armstrong, M
   Chilton, D
   Whitty, CJM
AF Lawn, SD
   Armstrong, M
   Chilton, D
   Whitty, CJM
TI Electrocardiographic and biochemical adverse effects of sodium
   stibogluconate during treatment of cutaneous and mucosal leishmaniasis
   among returned travellers
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE leishmaniasis; pentavalent; antimonials; sodium stibogluconate;
   toxicity; QT interval; travel
ID VISCERAL LEISHMANIASIS; EFFICACY; ANTIMONY; THERAPY; SAFETY
AB Use of parenteral pentavalent antimonials to treat leishmaniasis is associated with a range of cardiological, biochemical and haematotogical adverse effects. The most serious of these is the development of ventricular tachyarrhythmias associated with prolongation of the electrocardiographic rate-corrected QT interval (QTc). Whereas some studies have reported that serious cardiological and biochemical adverse effects are common and often require treatment interruption or discontinuation, others have reported the drugs to be well tolerated. We conducted a detailed retrospective analysis of adverse events among British returned travellers (n = 65) with New World cutaneous or mucosal Leishmaniasis who received i.v. sodium stibogtuconate (SbV) for >= 21 days. The mean +/- SEM QTc progressively increased from 389 +/- 3.1 msec to 404 +/- 2.9 msec during 3 weeks of treatment and the QTc reached the threshold for potential cardiac toxicity among 6 (10%) patients during the third week of treatment. Marked QTc prolongation and ventricular tachyarrhythmias occurred in one elderly patient with hypokalaemia and pre-existing cardiovascular morbidity. Although increased serum concentrations of amylase and hepatic transaminases were observed among 67% and 85% of patients respectively, none developed clinical pancreatitis or hepatitis and treatment modification was not required. SbV can be used safety in this population with adequate monitoring and the need for treatment interruption is uncommon. Identification of factors before and during treatment that may increase the risk of QTc prolongation and arrhythmias is important. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Hosp Trop Dis, London NW1 0PE, England.
RP Lawn, SD (corresponding author), London Sch Hyg & Trop Med, Clin Res Unit, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.
EM stevelawn@yahoo.co.uk
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027
CR Ahluwalia S, 2004, BMJ-BRIT MED J, V329, P842, DOI 10.1136/bmj.329.7470.842
   Aronson NE, 1998, CLIN INFECT DIS, V27, P1457, DOI 10.1086/515027
   BALLOU WR, 1987, LANCET, V2, P13
   CHULAY JD, 1988, T ROY SOC TROP MED H, V82, P69, DOI 10.1016/0035-9203(88)90267-2
   CHULAY JD, 1985, AM J TROP MED HYG, V34, P702, DOI 10.4269/ajtmh.1985.34.702
   DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J
   DEDET JP, 2003, MANSONS TROPICAL DIS, P1339
   GASSER RA, 1994, CLIN INFECT DIS, V18, P83, DOI 10.1093/clinids/18.1.83
   HEPBURN NC, 1993, LANCET, V342, P238, DOI 10.1016/0140-6736(93)92327-P
   HEPBURN NC, 1994, Q J MED, V87, P465
   HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127
   MCBRIDE MO, 1995, CLIN INFECT DIS, V21, P710, DOI 10.1093/clinids/21.3.710
   Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659
   Sundar S, 1998, AM J TROP MED HYG, V59, P139, DOI 10.4269/ajtmh.1998.59.139
   Thakur CP, 1998, ANN TROP MED PARASIT, V92, P561, DOI 10.1080/00034989859258
   Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363
NR 18
TC 45
Z9 46
U1 0
U2 1
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 1EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2006
VL 100
IS 3
BP 264
EP 269
DI 10.1016/j.trstmh.2005.03.012
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 011JQ
UT WOS:000235264800011
PM 16289167
DA 2020-12-01
ER

PT J
AU Moore, DAJ
   Grant, AD
   Armstrong, M
   Stumpfle, R
   Behrens, RH
AF Moore, DAJ
   Grant, AD
   Armstrong, M
   Stumpfle, R
   Behrens, RH
TI Risk factors for malaria in UK travellers
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE malaria; chloroquine/proguanil; mefloquine; travellers; The Gambia
ID FALCIPARUM-MALARIA; MOSQUITO BITES; PROPHYLAXIS
AB After observing an apparent increase in severe falciparum malaria among travellers returning from The Gambia to the United Kingdom (UK) in the last quarter of 2000, we conducted a case-controt study to investigate risk factors for malaria. The study participants had visited The Gambia between 1 September and 31 December 2000, travelling with the largest UK tour operator serving this destination. The main outcome measures were risk factors associated with malaria. Forty-six cases and 557 controls were studied. Eighty-seven percent of all participants reported antimalarial use (41% chloroquine/proguanil, 31% mefloquine). On univariate analysis the strongest risk factors for disease were: early calendar period of visit, longer duration of stay, non-use of antimalarial prophylaxis, non-use of mefloquine, tack of room air-conditioning, less use of insect repellent, prior visit to another malarial area and accommodation in 'hotel X'. After adjustment in multivariate analysis, use of mefloquine remained strongly protective (odds ratios, OR 0.13 [95% confidence intervals, 95% Cl 0.04-0.40]), and the strongest independent risk factors for malaria were early calendar period (OR 5.19 [2.35-11.45] for 1 September to 9 November 2000 versus 10 November to 31 December 2000), prior visit to another malarial area (OR 3.27 [1.41-7.56]), main accommodation in 'hotel X' (OR 3.24 [1.51-6.97]) and duration of stay (OR 2.05 per extra week [1.42-2.95]). Neither any use, nor >90% adherence to chloroquine/proguanil were protective (adjusted OR for any use 0.57 [0.27-1.21], P = 0.14). We concluded mefloquine use was strongly protective against malaria (87% protective efficacy), whereas chloroquine/proguanit, which is no longer recommended but remains widely used, was less than half as effective (43% protective efficacy). Waning efficacy of chloroquine/proguanit may have contributed to the observed increase in malaria among travellers to The Gambia in 2000. Local factors may also influence the risk of malaria. Malaria could be prevented among travellers to West Africa if current national guidelines on antimalarial prophylaxis were better implemented. (C) 2003 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Hosp Trop Dis, London WC1E 6AU, England.
   Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England.
RP Behrens, RH (corresponding author), Hosp Trop Dis, Mortimer Market,Capper St, London WC1E 6AU, England.
EM ron.behrens@tshtm.ac.uk
CR Bradley D J, 2001, Commun Dis Public Health, V4, P84
   BRADLEY DJ, 1997, COMMUN DIS REV, V7, P137
   DAVIDSON RN, 1993, J INFECTION, V26, P348, DOI 10.1016/0163-4453(93)96241-H
   Dorsey G, 2000, ARCH INTERN MED, V160, P2505, DOI 10.1001/archinte.160.16.2505
   Durrheim DN, 1999, BRIT MED J, V318, P1139, DOI 10.1136/bmj.318.7191.1139
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Guthmann JP, 2001, T ROY SOC TROP MED H, V95, P577, DOI 10.1016/S0035-9203(01)90084-7
   Jelinek T, 2002, CLIN INFECT DIS, V34, P572, DOI 10.1086/338235
   Keystone JS, 2001, J TRAVEL MED, V8, pS42
   Laver SM, 2001, J TRAVEL MED, V8, P298, DOI 10.2310/7060.2001.23975
   Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560
   PHILLIPSHOWARD PA, 1986, BRIT MED J, V293, P932, DOI 10.1136/bmj.293.6552.932
   Schoepke A, 1998, J TRAVEL MED, V5, P188, DOI 10.1111/j.1708-8305.1998.tb00505.x
   Schwartz E, 2001, CLIN INFECT DIS, V33, P1774, DOI 10.1086/322522
   STEFFEN R, 1990, B WORLD HEALTH ORGAN, V68, P313
   WILLIAMS A, 1987, BRIT MED J, V295, P1449, DOI 10.1136/bmj.295.6611.1449
NR 16
TC 25
Z9 26
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN
PY 2004
VL 98
IS 1
BP 55
EP 63
DI 10.1016/S0035-9203(03)00007-5
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 755RB
UT WOS:000187423600006
PM 14702838
DA 2020-12-01
ER

PT J
AU Sudarshi, S
   Stumpfle, R
   Armstrong, M
   Ellman, T
   Parton, S
   Krishnan, P
   Chiodini, PL
   Whitty, CJM
AF Sudarshi, S
   Stumpfle, R
   Armstrong, M
   Ellman, T
   Parton, S
   Krishnan, P
   Chiodini, PL
   Whitty, CJM
TI Clinical presentation and diagnostic sensitivity of laboratory tests for
   Strongyloides stercoralis in travellers compared with immigrants in a
   non-endemic country
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE S. stercoralis; serology; stool microscopy; eosinophil count;
   sensitivity; travellers; immigrants
ID LINKED-IMMUNOSORBENT-ASSAY; FAR-EAST PRISONERS; INTESTINAL PARASITES;
   LARVAL ANTIGENS; INFECTION; ELISA; EOSINOPHILIA; WAR; SCHISTOSOMIASIS;
   SERODIAGNOSIS
AB OBJECTIVES To assess whether the clinical and laboratory methods for diagnosing Strongyloides stercoralis infection in non-endemic countries is different between those who are chronically exposed and those who travel.
   METHODS Analysis of laboratory and clinical data from 204 patients having S. stercoralis infection at the Hospital for Tropical Diseases, London.
   RERSULTS Sixty-four travellers and 128 immigrants from endemic countries had laboratory-proven strongyloides. In those with microscopically proven disease, serology was 73% sensitive in travellers and 98% sensitive in immigrants (P < 0.001). There was no difference in the eosinophil count between the two groups with 19% having a normal count. Patterns of symptoms varied between the groups, and around one-third were asymptomatic in both groups. Serology was of limited use in follow-up.
   CONCLUSIONS Eosinophil count and stool microscopy are insufficiently sensitive to be used alone for screening strongyloides. The sensitivity of serology is good in immigrants with chronic infection, but lower in travellers.
C1 Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
   Hosp Trop Dis, London WC1E 6AU, England.
RP Whitty, CJM (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027
CR Adedayo AO, 2001, AM J TROP MED HYG, V65, P650, DOI 10.4269/ajtmh.2001.65.650
   ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545
   Atkins NS, 1997, T ROY SOC TROP MED H, V91, P609, DOI 10.1016/S0035-9203(97)90049-3
   BAILEY JW, 1989, ANN TROP MED PARASIT, V83, P241, DOI 10.1080/00034983.1989.11812338
   CARVALHO EM, 1983, T ROY SOC TROP MED H, V77, P346, DOI 10.1016/0035-9203(83)90162-1
   Chiodini PL, 2000, LANCET, V355, P43, DOI 10.1016/S0140-6736(99)02744-0
   CONWAY DJ, 1993, T ROY SOC TROP MED H, V87, P173, DOI 10.1016/0035-9203(93)90477-8
   DARTRY A, 1995, T ROYAL SOC TROPCIAL, V89, P342
   DRAPER CC, 1980, BRIT MED J, V280, P1575, DOI 10.1136/bmj.280.6231.1575
   GAM AA, 1987, AM J TROP MED HYG, V37, P157, DOI 10.4269/ajtmh.1987.37.157
   GANN PH, 1994, J INFECT DIS, V169, P1076, DOI 10.1093/infdis/169.5.1076
   GENTA RM, 1988, AM J CLIN PATHOL, V89, P391, DOI 10.1093/ajcp/89.3.391
   GILL GV, 1979, BRIT MED J, V2, P572, DOI 10.1136/bmj.2.6190.572
   GILL GV, 1989, ANN TROP MED PARASIT, V83, P249, DOI 10.1080/00034983.1989.11812339
   HARADA YOSHIMICHI, 1955, YONAGO ACTA MED, V1, P177
   JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428
   KOBAYASHI J, 1994, DIAGN MICR INFEC DIS, V18, P19, DOI 10.1016/0732-8893(94)90129-5
   LERMAN D, 1982, J FAM PRACTICE, V15, P443
   LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353
   LINDO JF, 1994, AM J TROP MED HYG, V51, P175, DOI 10.4269/ajtmh.1994.51.175
   MORGAN JS, 1986, TRANSPLANTATION, V42, P518, DOI 10.1097/00007890-198611000-00016
   Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006
   NEVA FA, 1981, J INFECT DIS, V144, P427, DOI 10.1093/infdis/144.5.427
   NUTMAN TB, 1987, J INFECT DIS, V155, P309, DOI 10.1093/infdis/155.2.309
   PELLETIER LL, 1988, J INFECT DIS, V157, P573, DOI 10.1093/infdis/157.3.573
   Sato Yoshiya, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P35, DOI 10.1590/S0036-46651995000100006
   Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026
   Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707
   Suvajdzic N, 1999, HAEMATOLOGIA, V29, P323
   Uparanukraw P, 1999, AM J TROP MED HYG, V60, P967, DOI 10.4269/ajtmh.1999.60.967
   Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4
NR 31
TC 72
Z9 75
U1 0
U2 0
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD AUG
PY 2003
VL 8
IS 8
BP 728
EP 732
DI 10.1046/j.1365-3156.2003.01069.x
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 703FE
UT WOS:000184268700008
PM 12869094
OA Bronze
DA 2020-12-01
ER

PT J
AU Whetham, J
   Day, JN
   Armstrong, M
   Chiodini, PL
   Whitty, CJM
AF Whetham, J
   Day, JN
   Armstrong, M
   Chiodini, PL
   Whitty, CJM
TI Investigation of tropical eosinophilia; Assessing a strategy based on
   geographical area
SO JOURNAL OF INFECTION
LA English
DT Article
ID SCHISTOSOMIASIS; STRONGYLOIDIASIS
AB Objectives: Patients with eosinophilia are an important clinical problem. This study aimed to assess the most efficient manner of investigating patients with peripheral eosinophilia (eosinophil count > 0.5 x 10(9) ml(-1)) presenting from the tropics.
   Methods: Patients attending the Hospital for Tropical Diseases, London, from October 1997 to March 2002 for investigation of eosinophilia were identified prospectively. Laboratory, clinical and demographic data were recorded from laboratory and clinical records. An investigation set was proposed prospectively and assessed for all geographical areas (stool microscopy, strongyloides culture and serology), all of Africa (additional schistosomal serology, terminal urine microscopy and filarial serology) and West Africa (additional day-bloods for microfilaria).
   Results: Data was analysed for 261 patients. At least one helminthic cause for eosinophilia was found in 64% of patients (median eosinophilia 1.2 x 10(9) ml(-1)). Seventeen per cent of patients had more than one helminth species found. Median eosinophilia increased with number of diagnoses per patient. The proposed investigation sets were validated, with high yield for all proposed tests apart from filarial serology outside West Africa, and good sensitivity.
   Conclusions: Initial investigation of eosinophilia in patients presenting from the tropics may be guided by a simple investigation set depending on broad area of travel which has high sensitivity and yield. Patients frequently have more than one helminthic cause of eosinophilia. (C) 2002 The British Infection Society. Published by Elsevier Science Ltd. All rights reserved.
C1 Hosp Trop Dis, London WC1E 6AU, England.
   Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.
RP Whitty, CJM (corresponding author), Hosp Trop Dis, Moritmer Market, Capper St, London WC1E 6AU, England.
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027
CR ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545
   BAILEY JW, 1989, ANN TROP MED PARASIT, V83, P241, DOI 10.1080/00034983.1989.11812338
   CHAKSAM A, 1980, THESIS U LONDON LOND
   FLECK SL, 1988, DIAGNOSTIC TECHNIQUE, P8
   FRYATT RJ, 1990, TROP GEOGR MED, V42, P119
   GENTA RM, 1987, JAMA-J AM MED ASSOC, V258, P48
   HARRIES AD, 1986, T ROY SOC TROP MED H, V80, P327, DOI 10.1016/0035-9203(86)90049-0
   LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353
   Liu LX, 1996, NEW ENGL J MED, V334, P382, DOI 10.1056/NEJM199602083340608
   MASTAFA MH, 1999, CLIN MICROBIOL REV, V33, P568
   MOHR E, 1992, J CLIN MICROBIOL, V30, P1572, DOI 10.1128/JCM.30.6.1572-1574.1992
   Moore TA, 1998, INFECT DIS CLIN N AM, V12, P503, DOI 10.1016/S0891-5520(05)70016-7
   NEVA FA, 1981, J INFECT DIS, V144, P427, DOI 10.1093/infdis/144.5.427
   Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026
   TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2
   Whitty CJM, 2000, TROP MED INT HEALTH, V5, P818, DOI 10.1046/j.1365-3156.2000.00642.x
   Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4
   WILSON ME, 1999, TROPICAL INFECT DIS, P1416
   WOLFE MS, 1992, INFECT DIS CLIN N AM, V6, P489
NR 19
TC 35
Z9 35
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0163-4453
J9 J INFECTION
JI J. Infect.
PD APR
PY 2003
VL 46
IS 3
BP 180
EP 185
DI 10.1053/jinf.2002.1108
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 661HE
UT WOS:000181884500007
PM 12643868
DA 2020-12-01
ER

PT J
AU Whitty, CJM
   Armstrong, M
   Behrens, RH
AF Whitty, CJM
   Armstrong, M
   Behrens, RH
TI Self-testing for falciparum malaria with antigen-capture cards by
   travelers with symptoms of malaria
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DIAGNOSIS; ASSAY
AB Kits for self-diagnosis of malaria by travelers in remote areas have been advocated. Antigen-capture test cards work reliably in the laboratory, but there is limited data regarding self-testing by ill patients. One hundred and fifty-three symptomatic patients presenting for a malaria test attempted self-diagnosis using these kits. Nine percent failed to perform a valid test. Against blood-film proven malaria, specificity was 97% (95% confidence intervals [CI] 93-99%) and sensitivity 95% (95% CI 74-99%). Although these results are encouraging, technical problems need to be addressed and test sensitivity proven by additional field-testing before this technology can be marketed to travelers.
C1 Hosp Trop Dis, Mortimer Market Ctr, London WC1E 6AU, England.
   Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1E 7HT, England.
RP Whitty, CJM (corresponding author), Hosp Trop Dis, Mortimer Market Ctr, Capper St, London WC1E 6AU, England.
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027
CR Bartoloni A, 1998, T ROY SOC TROP MED H, V92, P33, DOI 10.1016/S0035-9203(98)90945-2
   BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2
   Chiodini PL, 1998, LANCET, V351, P80, DOI 10.1016/S0140-6736(05)78155-1
   DIETZE R, 1995, AM J TROP MED HYG, V52, P45, DOI 10.4269/ajtmh.1995.52.45
   Funk M, 1999, T ROY SOC TROP MED H, V93, P268, DOI 10.1016/S0035-9203(99)90018-4
   Jelinek T, 1999, LANCET, V354, P1609, DOI 10.1016/S0140-6736(99)01969-8
   SCHLAGENHAUF P, 1995, B WORLD HEALTH ORGAN, V73, P215
   Trachsler M, 1999, TROP MED INT HEALTH, V4, P442, DOI 10.1046/j.1365-3156.1999.00419.x
   Williamson C, 1999, BRIT MED J, V319, P721, DOI 10.1136/bmj.319.7212.721
NR 9
TC 30
Z9 30
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV-DEC
PY 2000
VL 63
IS 5-6
BP 295
EP 297
DI 10.4269/ajtmh.2000.63.295
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 441VM
UT WOS:000169250300015
PM 11421381
OA Bronze
DA 2020-12-01
ER

PT J
AU Whitty, CJM
   Carroll, B
   Armstrong, M
   Dow, C
   Snashall, D
   Marshall, T
   Chiodini, PL
AF Whitty, CJM
   Carroll, B
   Armstrong, M
   Dow, C
   Snashall, D
   Marshall, T
   Chiodini, PL
TI Utility of history, examination and laboratory tests in screening those
   returning to Europe from the tropics for parasitic infection
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE health screening; parasites; tropics
ID SCHISTOSOMIASIS; TRAVELERS
AB OBJECTIVES To examine the utility of the different elements of screening expatriates and travellers returned from the tropics for parasitic disease (exposure history, symptoms, examination and laboratory tests).
   METHODS In phase 1 (conducted prospectively 1990-91), 1029 asymptomatic returnees had a detailed questionnaire and interview on risk-behaviour, physical examination and laboratory tests. In phase 2 (1997-98), 510 consecutive patients referred for routine screening (276 symptomatic and 234 asymptomatic) were screened with laboratory tests.
   RESULTS Exposure history did not correlate reliably with parasite burden. In phase 1 physical examination revealed 387 abnormalities, only three of which indicated parasitic disease. Schistosomal serology was positive in 11% (CI 9-13) of these asymptomatic cases including patients with light or no reported freshwater exposure. Stool microscopy was positive in 19% (CI 16-22) of cases not correlated with reported eating habits, and eosinophilia was present in 8% (CI 6-10). In phase 2 reported symptoms did not correlate with parasitic disease. Schistosomiasis was present in 15% (CI 13-24) of asymptomatic and 18% (CI 13-22) of symptomatic individuals (OR 1.2 P = 0.46); stool microscopy was positive in 14% of both symptomatic and asymptomatic patients, and eosinophilia in 9% of symptomatic and 6% of asymptomatic individuals.
   CONCLUSION Potentially serious asymptomatic infection is common in travellers. Detailed exposure history symptom history and physical examination added little to detecting cases. Stool microscopy, schistosomal serology and eosinophil count all had good yield. Filarial serology had low yield in patients without eosinophilia.
C1 Hosp Trop Dis, London WC1E 6AU, England.
   London Sch Hyg & Trop Med, Clin Res Unit, London, England.
   Foreign & Commonwealth Off, London, England.
   St Thomas Hosp, United Med & Dent Sch, London, England.
RP Chiodini, PL (corresponding author), Hosp Trop Dis, Mortimer Market,Capper St, London WC1E 6AU, England.
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027
CR ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545
   Brouwer ML, 1999, BRIT MED J, V318, P568, DOI 10.1136/bmj.318.7183.568
   CARROLL B, 1993, BRIT MED J, V307, P541, DOI 10.1136/bmj.307.6903.541
   CHAKSAM A, 1980, THESIS LONDON U LOND
   Day JH, 1996, BRIT MED J, V313, P268, DOI 10.1136/bmj.313.7052.268
   FLECK SL, 1988, DIAGNOSTIC TECHNIQUE, P8
   GENTA RM, 1987, JAMA-J AM MED ASSOC, V258, P48
   GOKA AKJ, 1990, T ROY SOC TROP MED H, V84, P829, DOI 10.1016/0035-9203(90)90098-Y
   HARRIES AD, 1986, LANCET, V1, P86
   LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353
   MacLean JD, 1998, INFECT DIS CLIN N AM, V12, P431, DOI 10.1016/S0891-5520(05)70012-X
   MacPherson DW, 1999, MED CLIN N AM, V83, P1053
   MOHR E, 1992, J CLIN MICROBIOL, V30, P1572, DOI 10.1128/JCM.30.6.1572-1574.1992
   SHABDE N, 1990, BRIT MED J, V301, P800, DOI 10.1136/bmj.301.6755.800
   SINNIAH B, 1982, PARASITOLOGY, V84, P167, DOI 10.1017/S0031182000051763
   TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2
   WHITTY CJM, 2000, IN PRESS T ROYAL SOC, V94
NR 17
TC 38
Z9 39
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 2000
VL 5
IS 11
BP 818
EP 823
DI 10.1046/j.1365-3156.2000.00642.x
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 380CQ
UT WOS:000165681100011
PM 11123831
DA 2020-12-01
ER

PT J
AU Whitty, CJM
   Mabey, DC
   Armstrong, M
   Wright, SG
   Chiodini, PL
AF Whitty, CJM
   Mabey, DC
   Armstrong, M
   Wright, SG
   Chiodini, PL
TI Presentation and outcome of 1107 cases of schistosomiasis from Africa
   diagnosed in a non-endemic country
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE schistosomiasis; Schistosoma mansoni; Schistosoma haematobium;
   diagnosis; screening; treatment failure
ID MANSONI INFECTION; PRAZIQUANTEL; TROPICS; TRIALS
AB Schistosomiasis is found in a significant proportion of returning travellers and immigrants to Britain. This study is a retrospective review of 1107 consecutive cases of schistosomiasis from Africa diagnosed by microscopy or serology presenting to the Hospital for Tropical Diseases, London, UK. 50(.)4% of cases were asymptomatic. The most common symptom which resolved on treatment was tiredness. Serology was positive in 951 (86%), and ova seen in 45%. Urine dipstick testing was positive for blood in 21% and protein in 15%, with eosinophilia in 44%. In this population urine dipstick, full blood count and serology were all insufficient screening tools used alone. Among patients with full follow-up data 3 months or more after treatment with praziquantel, definite treatment failure occured in 4 of 271 (1(.)5%),restricting the analysis to those with ova seen at diagnosis. There was no significant difference in treatment failure between 1 and 3 days of treatment. Antibody level was the same or higher than at treatment in 55% of cases seen after about 3 months and 38% after 1 year, confirming it is probably of limited clinical use in detecting treatment failure.
C1 Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England.
   Hosp Trop Dis, London WC1E 6AU, England.
RP Mabey, DC (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Keppel St, London WC1E 7HT, England.
RI Whitty, Christopher/C-7740-2012
OI Whitty, Christopher/0000-0002-6076-5027; Mabey,
   David/0000-0002-0031-8276
CR AbuElyazeed RR, 1997, AM J TROP MED HYG, V56, P404, DOI 10.4269/ajtmh.1997.56.404
   ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545
   DAVIS A, 1979, B WORLD HEALTH ORGAN, V57, P773
   Day JH, 1996, BRIT MED J, V313, P268, DOI 10.1136/bmj.313.7052.268
   FLECK SL, 1988, DIAGNOSTIC TECHNIQUE
   HARRIES AD, 1986, LANCET, V1, P86
   HASSAN F, 1979, J TROP MED HYG, V82, P3
   KARDAMAN MW, 1993, ANN TROP MED PARASIT, V77, P297
   KATZ N, 1979, B WORLD HEALTH ORGAN, V57, P781
   LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353
   MCMAHON JE, 1979, BRIT MED J, V2, P1396, DOI 10.1136/bmj.2.6202.1396
   MOTT KE, 1983, LANCET, V1, P1005
   PUGH RNN, 1984, T ROY SOC TROP MED H, V78, P55, DOI 10.1016/0035-9203(84)90172-X
   Rabello ALT, 1997, CLIN INFECT DIS, V24, P304, DOI 10.1093/clinids/24.3.304
   TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2
   VISSER LG, 1995, CLIN INFECT DIS, V20, P280, DOI 10.1093/clinids/20.2.280
   WILKINS HA, 1987, J TROP MED HYG, V90, P83
   ZWINGENBERGER K, 1990, ANN TROP MED PARASIT, V84, P457, DOI 10.1080/00034983.1990.11812495
NR 18
TC 101
Z9 105
U1 0
U2 5
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 1EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD SEP-OCT
PY 2000
VL 94
IS 5
BP 531
EP 534
DI 10.1016/S0035-9203(00)90077-4
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 379YD
UT WOS:000165670000016
PM 11132383
DA 2020-12-01
ER

PT J
AU ARMSTRONG, MS
AF ARMSTRONG, MS
TI DISCLOSURE - CONSIDERING OTHER VIEWS
SO FINANCIAL EXECUTIVE
LA English
DT Article
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FINANCIAL EXECUTIVES INST
PI MORRISTOWN
PA 10 MADISON AVE, PO BOX 1938, MORRISTOWN, NJ 07960
SN 0883-7481
J9 FINANC EXECUTIVE
PY 1976
VL 44
IS 5
BP 36
EP 40
PG 5
WC Business, Finance; Mathematics, Interdisciplinary Applications
SC Business & Economics; Mathematics
GA BQ429
UT WOS:A1976BQ42900004
DA 2020-12-01
ER

EF